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If binding and bending are really important for the biological function of SRY 
proteins, these features will be positively selected and conserved during evolution. 
The second part of this work demonstrates that the architecture and stability of 
nucleoprotein complexes formed by the DNA-binding domains of SRY proteins is 
indeed of primary importance. It is shown that these parameters are conserved 
amongst primates, irrespective of the time since divergence from a common ancestor 
or the number of residues which have changed during evolution. 
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Since 1953 (Jost, 1953) it was known that the presence of testes during mammalian 
embryogenesis resulted in male differentiation of the internal reproductive organs 
and external genitalia, while the presence of ovaries or the complete absence of 
gonads resulted in female differentiation. He deduced that the secretion of testicular 
hormones during a critical period in embryogenesis redirected differentiation of the 
reproductive tract from a female to a male pathway. Subsequently, the presence or 
absence of aY chromosome was shown to correlate with male or female phenotype: 
XY and XXY individuals are male, while XO and XX individuals are female. Yet the 
studies by Jost (1953), made clear that the Y chromosome-encoded mediator of sex 
determination needed only specific male gonadal development, and it was therefore 
called testis determining factor (TDF in humans, Tdy in mice). It is now accepted 
that, apart from the gonads, all morphological differences between male and female 
eutherian mammals result from the action of two testicular hormones, Mullerian 
inhibiting substance ( MIS or AMH) and testosterone. MIS is a member of the TGF 
beta family of growth factor, is secreted by Sertoli cells and causes regression of the 
Mullerian ducts, which would otherwise develop to form the uterus, cervix, fallopian 
tubes, and part of the vagina. Testosterone, secreted by Leydig cells, induces the 
development of male structures, derived from the Wolffian duct, including the 
epididymis, vas deferens, and seminal vesicles. The formation of male rather then 
female external genitalia requires the conversion of testosterone into 
dihydrotestosterone by steroid alpha reductase in the target tissue. The 
embryogenesis of mammalian sexual dimorphism has thus been divided into primary 
and secondary sex differentiation, the former referring to the development of the 
bipotential gonads into testes or ovaries, and the latter evocative of subsequent 
hormonal effects. 
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1.1 SRY: A SEXY STORY 
In a set of experiments, Koopman et al, (1991) demonstrated that XX mice differing 
from their sisters by addition of a single 14 Kb DNA fragment from the mouse Y 
chromosome including the SRY gene, can develop as phenotypic male. Though devoid 
of spermatogonia, the testes of these transgenic XX male mice appear to have a 
normal hormonal function; the mice display normal male secondary sexual 
differentiation and mating behavior. In contrast, XY mice differing from normal XY 
males only by the deletion of aY DNA fragment, 11 Kb including the SRY gene, 
develop as phenotypic females. These XY female mice are fertile and can transmit the 
mutant Y chromosome to their offspring (Lovell-Badge and Robertson, 1990; Gubbay 
et al., 1992). Thus, as judged by gonadal histology and hormone production, the 
presence and absence of SRY is sex determining in mice. Interpretation of the data 
from humans is less straightforward, though rare sex-reversed individuals provide 
counterparts to both XX male and XY female mice. Crossing over normally occurs 
near the short arm telomers of the human X and Y chromosomes during male meiosis, 
and aberrant recombination occurring more proximal can transfer fragments of Y- 
specific DNA (including SRY) into the genome of an otherwise XX individual. Most 
such translocations are cytologically undetectable, and the resulting XX males do not 
produce spermatozoa but have normal male internal and external genitalia. When 
small (35 Kb) fragments of Y-specific DNA are translocated, the resulting XX+SRY 
individuals invariably have genital abnormalities, sometimes despite apparently normal 
testicular histology (Palmer et. al., 1989). These abnormalities may include "sexually 
ambiguous" external genitalia (incomplete fusion of the labioscrotal folds with a 
resultant bifid scrotum or displaced urethra opening), undescended testes, or 
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ovotestes (gonads containing areas of both testicular and ovarian histology) with 
persistence of female structures derived from the Mullerian duct. There are several 
possible explanations for the phenotypic differences between these XX+SRYhumans 
and XX+SRY transgenic male mice. Perhaps the most likely scenario is that SRY 
transcription is reduced in XX+SRY humans (Palmer et. al., 1989). This could result 
from the spread of X inactivation across a nearby X; Y translocation breakpoint in 
humans. The murine SRY transgene would not be subject to this effect if it inserted at 
an autosomal locus. Alternatively, loss of regulatory sequences 5' of the human SRY 
gene might result from X; Y translocation involving only small amounts of Y-specific 
DNA. It is unclear whether reduced expression of SRY could explain the phenotype; 
presumably decreased or delayed hormonal action would have to result. It remains a 
formal possibility that, in humans, but not in mice, full development of the male 
phenotype requires expression of a second Y-linked gene, located near SRY and 
perhaps expressed outside the testis. In contrast with XY female mice, XY female 
humans are sterile; some of these individuals have mutations affecting the SRY open 
reading frame (Berta et. al., 1990). Such XY individuals fail to develop mature testes 
or ovaries and instead form poorly differentiated gonads without clear male or female 
histology. Because the gonads lack male hormonal function, Mullerian structures 
persist and female secondary sexual differentiation follows. Infertility may result in 
part from X chromosome monosomy: unlike XO mice, XO humans are sterile. 
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1.2 SEXUAL COMMITMENT AND SRY TRANSCRIPTION. 
The mammalian gonad is composed of germ cells and three types of somatic cells. 
Primordial germ cells, which are first observed in the extraembronic mesoderm 
(Ginsburg et al., 1990), migrate into the primitive gonad at 10.5-12 days post coitum 
(dpc) in the mouse. The somatic portion of the gonad is composed of supporting cells 
(Sertoli cells in the male and follicle cells in the female, thought to derive from 
common progenitors), steroidogenic cells (Leydig cells in the male and theca cells in 
the female), and connective tissue cells. When is gonadal sex determined? Though the 
sexual fate of an embryo is set at fertilisation, it is not known when gonadal cells 
become committed to male or female development. XX and XY mouse embryos are 
morphologically indistinguishable until 11.5-12.5 dpc, when pre Sertoli cells align to 
form testis cords in the XY gonad. By this time a male or female developmental 
program has clearly been initiated. Yet it is not obvious that sex determination 
(commitment) is coincident with the onset of sex differentiation (e. g. histologic 
change). When does the presence or absence of SRY protein result in irreversible 
commitment to male or female differentiation? Barring pleiotropic effects of SRY, it is 
reasonable to suppose that sex differentiation begins when SRY is first expressed. 
Initial experiments suggested that this is from 10.5 to 12.5 dpc in the murine gonads. 
Sry was previously shown to be expressed by germ cells in adult mouse testis 
surprisingly as a circular transcript that seems not to be translated (Capel et al., 1993). 
The embryonic promoter is turned on specifically in the genital ridge at about 10.5-11 
dpc, just before the morphological differentiation between sexes is observed and is 
turned off at about 12.5 dpc. Sry expression in the preimplantation mouse embryo has 
been reported (Zwingman et al., 1993). Althought there is still doubt about these 
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findings, the trancript present in pre implantation embryos may have no function and 
they could all be circular. Moreover there is no evidence for any function for Sry at 
this stage and a role in sex determination seem highly unlikely. 
If it is not compleately clear when sex determination begins, it is equally unclear when 
it finishes. By 13.5 dpc, Sry transcripts are no longer detectable by PCR of gonadal 
RNA (Koopman et al., 1990). While it is not known how long SRY protein persists, 
the function of the Y chromosome in determining the sex of the embryo appears to be 
complete by this time. Given that other proteins must be involved, sexual 
commitments could still be in flux at the time of the disappearance of SRY. 
In which cells do the initial steps in gonadal sex determination occur? Not in the germ 
cells: in mouse embryos that are defective in migration of primordial germ cells to the 
gonad, the process of gonadal differentiation is otherwise undisturbed (reviewed by 
McLaren, 1991). XY animals still develop testes, and XX animals still begin to 
develop ovaries (although follicles will not form). Sex determination must unfold in 
the somatic cell lineage of the gonad. 
In which of the somatic lineage, then, does gonadal sex determination occur? 
Experiments involving XX -- XY chimeric mice, reminiscent of mosaic analysis in 
invertebrates, have sought to identify gonadal cell lineages that become committed to 
male or female development as a direct result of the presence or absence of the Y 
chromosome. These should be the cell lineages in which sex determination initiates. If 
sex determination occurs autonomously in each gonadal cell, then all of XY cells in a 
chimeric gonad should be male and all of XX cells should be female. If, on the other 
hand, the sexual phenotype of a gonadal cell is determined in consultation with its 
neighbors, then the strict correlation of chromosome constitution with cellular 
phenotype should break down. In chimeric mice with testes, the proportion of XX and 
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XY cells in the Leydig population are similar to those seen outside the gonad, 
implying that sex determination does not occur autonomously in Leydig cell 
precursors. In contrast, most but not all Sertoli cells are XY, indicating some direct 
action by the Y chromosome, presumably by Sry (Patek et al, 1991; Palmer and 
Burgoine, 1991). The presence of a few XX Sertoli cells in XX --XY embryos 
indicates that cells lacking Sry can be recruited into the Sertoli population. The 
mechanism by which such recruitment occurs is unknown. Complementary studies in 
XX-XY chimeras with ovaries show that XY precursors can become follicle cells, the 
female counterparts of Sertoli cells. The major conclusion that can be drawn from 
these experiments is that the initial steps that commit the gonad to male or female 
differentiation likely occur in the supporting cell lineage (i. e., in pre Sertoli or 
prefollicle cells). Since Sry encodes a nuclear factor and must be expressed and 
function within the cells that carry out these steps, it is presumably expressed in pre- 
Sertoli cells. 
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1.3 PATHWAYS AND GENES INVOLVED IN SEX DIFFERENTIATION 
Apart from what was reviewed above, rather little is known about the molecular 
nature of gonadal differentiation in mammals, although there is a substantial 
knowledge of the cellular processes that occur during early testis and ovary 
development. The first cells to be differentiated by the action of SRY in the developing 
genital ridge are the Sertoli cells, and they in turn direct the differentiation of the other 
cell type in the testis (Burgoyne et al., 1988). The timing of SRY action during 
development is critical, the SRY gene is normally necessary and sufficient to determine 
testis differentiation, but nothing is known about the genes it regulates to produce this 
effect. 
Sex reversed patients have been the main source of information on candidate sex 
determination genes. The establishment of epistatic relationship between these genes 
and SRY, however, must await their analysis in the mouse. The gene for a severe 
dwarfism syndrome, campomelic dysplasia, often associated with XY female sex 
reversal, has been cloned (Wagner et al., 1994; Wright et al. 1995; Foster et al. 1994). 
The gene encodes a protein related to SRY, and has been named Sox9. The 
phenotype of these patients is associated with inactivating mutations within the open 
reading frame of Sox 9 or with translocations at some distance upstream of the gene. 
These mutations are present in only one allele of the gene, suggesting that sex reversal 
and campomelic dysplasia in these patients could be due to haploinsufficiency of the 
Sox 9 gene product. Sox9 expression was found to closely follows differentiation of 
Sertoli cells in the mouse testis and the timing and the cell type specificity of Sox9 
expression suggests that Sox9 may be directly regulated by SRY (Da Silva et al., 
1996; Kent et al., 1996). Another case of dosage sensitive sex reversal in humans is 
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found in XY females that have duplications in a region of the short arm of the X 
chromosome. One model for this effect assumes that this region contains a gene, 
termed DSS for dosage-sensitive sex reversal, with encodes a female specific function. 
Perheps this is be negatively regulated by SRY in males, but this repression fails when 
the gene is present in a double dose or not X inactivated. A gene that encodes a 
member of the nuclear hormone receptor superfamily has been cloned from this 
region. This geneis responsible for the condition known as adrenal hypoplasia 
congenital (AHC) and has therefore now been named DAX-1 for DSS-AHC critical 
region on the X chromosome (Zanaria et. at., 1994; Bardoni et al., 1994). Dax-1 is 
expressed in the genital ridge in mice at 11.5 dpc, consistent with a role in sex 
determination, but apparently at similar levels in both female and males. By 12.5 dpc, 
Dax-1 is switched off in the male gonad, but remains on in females (Swain et al 
1996). If it is a candidate for a female specific function that is negatively regulated in 
males, any repression will be post transcriptional. Studies in mice on another member 
of the nuclear hormone receptor superfamily, the steroidogenic factor I (SFI) gene, 
has shown that it is involved in gonad development and possibly in sex determination. 
The SF1 gene was first identified as a factor that regulates steroidogenic enzymes in 
the adrenal cortex and gonads (Rice et al., 1991; Lala et at., 1992; Honda et al., 
1993). However, SF1-deficient mice showed a complete absence of gonads as well as 
adrenals, implying that the gene has a function in the initial development of these 
organs before SRY is turned on (Luo et at., 1994).. SF1 has also been implicated in 
sex determination because of its sexually dimorphic expression in the gonad. In fact 
during the sexually undifferentiated stage of gonadal development (9-12 dpc), all 
embryos express SF1 in the genital ridge. As testicular cords form in males, SFI 
transcripts are diffusely expressed throughout the testes. By Northern blotting and in 
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situ hybridisation SF1 expression is shown in Sertoli cells (Ikeda et al., 1994). In 
contrast to its persistent expression in the embryonic testes, SF1 transcripts disappear 
from the ovary between 13-16.5 dpc, reappearing only during late gestation (Ikeda et 
al., 1994). Coupled with the demonstration of SF1 mRNA in Sertoli cells, these data 
suggest that SF1 plays a role in gonadal development. Indeed male and female SF1 
null mice had female internal genitalia, despite complete gonadal disgenesis. These 
studies establish that the gene coding SF I is essential for sexual differentiation and 
formation of the primary steroidogenic tissues (Luo et al., 1994). Furthermore, in 
primary Sertoli cells, SF1 regulates the MIS gene by binding to a conserved upstream 
regulatory element and can activate its transcription in cotransfection assays. In 
heterologous HeLa cells, MIS gene activation by SF I requires removal of the SF I 
ligand-binding domain, implicating a Sertoli cell-specific ligand or cofactor (Shen et 
al., 1994). Since sexually dimorphic expression of SF I during development coincides 
with MIS expression and Mullerian duct regression, SF1 is proposed to regulate MIS 
in vivo and participate directly in the process of mammalian sex differentiation (Shen 
et at, 1994). However, because it is expressed earlier and in both sexes, SF I alone 
cannot account for the testis-specific activation of MIS expression at 11.5 dpc. 
Several studies have implied that SRY does not directly activate MIS but acts through 
an unidentified factor. Differential patterns of expression in the male mouse gonad at 
the time where SRY is thought to act are found for MIS and for desert hedgehog, a 
member of a family of proteins that are known to be important in cell signalling. 
However, mice deficient in either of these genes do not show a phenotype consistent 
with a role in sex determination (Behringer et al., 1994). Recent results show that 
AMH mutations in mice modify the regression of Mullerian ducts and suggested that 
it might be involved in the control of proliferation of steroidogenic cells in the testis. 
21 
From all these results sex determination in mammals appears to be a puzzle of several 
genes whose function is far from completely understood. 
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1.4 SRY PROTEIN AND HMG BOX DOMAIN: A GENERAL OVERVIEW. 
The human SRY gene encodes a protein with a central high mobility group domain 
(HMG box) of about 78 amino acids. This box is also present and conserved in 
several eukaryotic proteins. It is a DNA binding domain recently discovered and first 
recognised by sequence alignments of hUBF, a transcription factor for human RNA 
polymerase I, with HMG1, an abundant and strongly conserved component of 
mammalian chromatin (Jantzen et al., 1990). Several additional members of the HMG 
family have since been described. Sequence analysis of this family indicates that the 
HMG box is a minimally stretch of about 70 amino acids, with a net positive charge 
and an abundance of aromatic residues and prolines. Among the members of this 
family the similarity of the primary sequences of HMG boxes is modest: no residue is 
absolutely conserved, and just three residues show only conservative substitutions in 
all known HMG boxes (Fig. 1). The sequence variation between HMG boxes is 
paralleled by the diversity of their presumed biochemical functions. One subgroup of 
proteins is clearly related to HMG1 and comprises structural components of 
eukaryotic chromatin. HMG1-like proteins are present in all eukaryotes and in all 
tissues of higher organisms. However their physiological function remains elusive; 
roles have been suggested in DNA replication, in nucleosome assembly and in 
transcription (reviewed by Bustin et al., 1990, and Bianchi et al., 1992a). Another 
subgroup of proteins comprises general transcription factors of RNA polymerase I 
and mitochondrial RNA polymerase; some of these proteins, such as hUBF (Jantzen 
et al., 1990), contain HMG boxes as moderately repeated elements. A third subgroup 
has recently attracted much interest: it comprises a number of fungal proteins involved 
in mating-type expression (Staben and Yanofsky, 1990; Sugimoto et al., 1991), the 
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mammalian testis determining factor SRY (Gubbay et al., 1990; Sinclair et al., 1990), 
the protein product of Sox genes and a set of lymphoid-specific enhancer binding 
factors (Travis et al., 1991; van de Wetering et al., 1991; Waterman et al., 1991). 
These proteins are most likely transcriptional regulators: protein LEF-1, for example, 
is expressed specifically in pre-B and T lymphocytes and is involved in the 
transcription of the gene for the T cell receptor alpha chain (Travis et al., 1991; 
Waterman et al., 1991). 
Up to now there is no clear evidence of the function of the portion of SRY proteins 
outside the HMG box. Also within mammals, the comparison of SRY proteins during 
evolution shows that protein segments flanking the HMG-box are highly variable in 
sequence and length and cannot be aligned (Whitfield et al., 1993; Tucker et al., 
1993). This feature is also shared within primates, where the C-terminal domain varies 
extensively. All these data may be explained by if all the functions of SRY reside in 
the highly conserved HMG-box. Another possibility is that natural selection favors the 
fast adaptive divergence of the non-box regions. In accordance with the first 
hypothesis, the importance of the HMG box is underlined by the analysis of human 
sex reversed XY females. All the single point mutations of the hSRY gene found in 
patients associated with sex reversal phenotypes fan within the HMG box. 
Both NLS motifs are conserved in the HMG-boxes of other transcription factors, and 
are supposed to act as a bipartite basic motif, both able to independently direct the 
protein into the nucleus. 
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1.5 DNA BINDING 
HMG boxes from all three subgroups have been shown to be necessary and sufficient 
to bind DNA: the two HMG boxes of HMGI have been produced in E. coli as 
separate polypeptides, which bind to DNA with about the same affinity and specificity 
as the full-length protein (Bianchi et al., 1992b); Xenopus UBF binds to DNA via its 
boxes (McStay et al., 1991); some mutations in the HMG box of human SRY can 
abolish its capacity to bind to DNA as well as its biological activity (Berta et al., 1990; 
Harley et al., 1992), and the isolated HMG box of LEF-1 retains the DNA binding 
properties of the whole protein (Giese et al., 1992). HMG boxes are therefore 
authentic DNA binding domains, which can fold independently from the rest of the 
polypeptide. The nature of the DNA targets recognised by HMG boxes, however, is 
not obvious. A common feature of all HMG boxes is that they have considerable 
affinity and specificity towards bent DNA, e. g. as cruciform structures, irrespective of 
their sequences. The HMG box chromatin proteins (subgroup 1) seem to be 
indifferent to DNA sequence information. They only share with the HMG box family 
the considerable affinity and specificity towards four-way DNA junctions and 
cruciform structures, such as those extruded from inverted repeat sequences under the 
effect of supercoiling (Bianchi, 1994; Lilley, 1992). The HMG-box proteins of 
subgroup 2 (the nucleolar and mitochondrial transcription factors), while still 
endowed with sufficient sequence discrimination to produce specific footprints, do not 
bind to DNA sites with a recognisable consensus sequence (Pikaard et al., 1990 ab; 
Parisi and Clayton, 1991). Therefore the binding to DNA does not seem to depend 
entirely on sequence recognition. The transcriptional regulators (subgroup 3) produce 
specific footprints on DNA, spanning sequences with a recognisable consensus 
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(Waterman et al., 1991; Nasrin et al., 1991; Travis et al., 1991). Human SRY can 
recognize synthetic duplex DNA fragments of the sequence AACAAAG (Harley et 
al., 1992). Methylation interference and base substitution experiments show that LEF- 
1 and the related TCF-1 proteins recognize the AACAAAG motif predominantly 
through minor groove contacts (Giese et al, 1991,1992; van de Wetering and 
Clevers, 1992), where the recognition of bases is therefore restricted. This limits their 
binding specificity; for example numerous substitutions in the target site of SRY are 
allowed (Harley et al., 1992) and specific and non-specific binding affinities differ by a 
factor of only 20 to 50 (Ferrari et al., 1992). Upon binding, these proteins distort the 
DNA to dramatic extents: SRY produces a bend of about 80 degrees centered at the 
GAACAAAG sequence in the CD3e enhancer (Ferrari et al., 1992). Genetic 
experiments have identified the weakly related sequences RAACAAAGAA and 
GAGAACAATRR as the consensus target sites of the fungal protein Stell 
(Sugimoto et al., 1991). In general, all the binding sites for the HMG-box 
transcriptional regulators are AT-rich, and the same sequences are recognised by 
several proteins of this group. HMG box transcription regulators of this family upon 
binding induce a sharp angle in their DNA consensus sequence. Although fairly low, 
the sequence specificity of each individual protein is compatible with a function in 
gene-specific transcription regulation. The role of the DNA binding and bending 
ability of the HMG box is so far elusive, at least for SRY. 
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1.6 BINDING, BENDING AND BIOLOGICAL EFFECT OF HMG BOX. 
HMGI has been recently purified as the factor able to increase the binding between 
human progesterone receptor (PR) and its DNA binding site, the progesterone 
response element (PRE). This effect appears to be highly selective for HMG I, and the 
increase in binding affinity for a partial palindromic PRE present in natural targets 
genes was greater than 10 fold. 
Because HMG boxes of HMGI stimulate the binding and can flex DNA it could be 
possible that HMG1 facilitates the binding of PR inducing a structural change in the 
target DNA (Onate et al., 1994). A similar role could be played by the protein HMG2 
in another context. This protein increases the DNA binding activity of octamer 
transcription factors (OCT proteins), supporting these factors in their role as 
transcriptional activators (Zwilling et al., 1995). 
UBF, the upstream binding factor of RNA polymerase I, can also bend linear DNA 
inducing positive supecoiling, suggesting that UBF wraps the DNA. Additional 
studies provide evidence that wrapping DNA is produced in a right handed direction, 
opposite to the nucleosome' s one. 
UBF-induced DNA wrapping could be a mechanism by which UBF counteracts 
histone mediated gene repression. 
Protein LEFI contains, like SRY, one HMG box domain that induces a sharp angle in 
the DNA. This protein recognises a DNA consensus sequence on the T cell receptor 
alpha gene enhancer; the minimal enhancer element was shown to contain binding 
sites for at least others two distinct factors, flanking the binding site of LEF 1. All 
three sites are recognised for enhancer function. A series of experiments revealed that 
mutations that alter the relative positions of the three sites inactivate the enhancer. 
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Moreover, it appeared that LEF 1 protein cannot activate transcription on its own, but 
must act in concert with factors that bind to the other two sites of the enhancer. 
By using LEF1 in a different context it is also possible to study the connection of its 
HMG box and the in vivo topology of DNA . 
This protein is in fact able to interact 
with its DNA binding site in the human HIV I enhancer. By using a nucleosome- 
assembly system derived from Drosophila embryos, it was found that the packaging of 
DNA into chromatin, in vitro, strongly represses HIV I transcription and that 
repression can be counteracted efficiently by preincubation of DNA with LEF 1 
supplemented with a fraction containing the promoter binding protein Sp l (Sheridan 
et al., 1995). This observation and additional studies of LEF1 ability to bend DNA led 
to the proposal that LEF1 acts as an architectural component in the assembly of the T 
cell enhancer complex. According to this model, LEF 1 induces a bend in DNA so 
that transcription factors bound to recognition sequences flanking the LEF I binding 
site can interact with each other. 
SRY action could be explained in the same way. Proteins bound at either side of the 
SRY binding site may then be brought into close contact and form a stable complex. 
In turn, the complex would freeze the deformation of the DNA molecule, and 
indirectly stabilise the binding of SRY. In fact, it was shown previously that SRY 
binds with high affinity to distorted DNA molecules, like four-way junctions, 
irrespective of their sequence (Ferrari et al., 1992). This possible role is supported by 
two pieces of evidence: 
1) among different species, the only part of the protein conserved is the HMG box 
domain. 
2) the only mutations in SRY known to cause sex-reversal in humans fall within the 
HMG-box domain (Berta et al., 1990, Hawkins el al., 1992, Hawkins, 1994 ). 
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To find evidence for a possible role of the DNA bending activity of the HMG box of 
SRY in gene expression and differentiation, and a possible correlation between an 
anomalous geometry of the DNA-protein complex and a biological effect of the 
mutation, we analysed SRY mutants associated with sex-reversal in humans. Five 
mutations with varying degrees of severity were considered. Moreover, we considered 
also the behavior of seven SRYs from different primates that, irrespective of 
substitutions occurring within the HMG box, have biological functions selected by 
evolution. 
Five mutations with varying degrees of severity were considered. Mutations F109S 
and 190M were associated with complete gonadal dysgenesis in the patients where 
they were first identified, but were also present in normal male relatives of the 
patients, including the father (Hawkins et al., 1992b; Jager et al., 1992). These 
mutations therefore have low penetrance, are transmissible, and may cause a 
differentiation defect only in specific environments or in association with specific 
genetic backgrounds. Mutations G95R and M64I were identified only in patients with 
complete gonadal dysgenesis but not in their relatives, and have arisen de novo (Berta 
et al., 1990; Hawkins et al., 1992a). Mutation K106I was also associated with 
complete gonadal dysgenesis, but no male relatives of the patient were available for 
testing (Hawkins et at., 1992b). 
29 
RESULTS 
2.1 PRODUCTION OF WILD TYPE AND MUTANT SRY DNA BINDING 
DOMAINS 
We first chose to compare HMG box A of rat HMGI (HMG1bA, amino acids -8 to 
81 in the numeration of figure 1) with the HMG box of human SRYs, identified on the 
basis of its sequence similarity to other HMG boxes (Sinclair et al., 1990; figure 1). 
To express and study protein mutations of HMG boxes, it was first necessary to 
subclone their DNA coding sequences. Since the SRY gene does not contain introns, 
DNA fragments coding for the HMG box of normal and mutant human SRY were 
obtained by polymerase chain reaction (PCR) of total genomic DNA with specific 
oligonucleotides. 
PCR is a method for amplifying DNA enzymatically. The first step simply entails 
mixing template DNA, two appropriate oligonucleotide primers, Taq DNA 
polymerase, deoxyribonucleoside triphosphates (dNTPs), and a buffer. The mixture is 
then cycled many times (in this case 25) through temperatures that permit 
denaturation, annealing, and synthesis in order to exponentially amplify a product of 
specific size and sequence. The PCR products are then displayed on an appropriate 
gel and examined for yield and specificity. The oligonucleotides used in our 
experiments contain two restriction enzymes sequences (NdeI-HindIII) in order to 
subclone the PCR fragments in the expression vector pT7-7. This vector (Studier et 
al, 1991) is a T7 expression vector containing the T7 promoter upstream of the gene 
to be expressed. The vector is designed for the exclusive expression of the cloned 
gene. This vector can then be used for production of intact native proteins by fusing 
coding sequences at the Mel site immediately preceding the ATG. In addition to the 
promoter, this vector contains also a ribosome binding site. In E. coli the ribosome 
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binding site includes an initiation codon (ATG) and a sequence 3-9 nucleotides in 
length located 3-9 nucleotides upstream of the initiation codon. This sequence, which 
is called the Shine Delgarno (SD) sequence, is complementary to the 3' terminus of E 
coli 16S rRNA. Binding of the ribosome to mRNA is thought to be promoted by base 
pairing between the SD sequence in the mRNA and the sequence at the 3' terminus of 
the 16S rRNA. 
Another factor required to express cloned DNA with this system is bacteriophage T7 
RNA polymerase. This polymerase recognises solely bacteriophage T7 promoters; it is 
a very processive RNA polymerase, and may transcribe sequences that are not 
efficiently transcribed by E. coli RNA polymerase; this system allows high levels of 
expression of some genes that are not expressed efficiently in other systems. T7 
polymerase is the product of bacteriophage T7 gene 1 and can be provided on an 
infecting bacteriophage lambda vector or produced from a gene copy inserted into E 
coli chromosomes. If expression of the cloned gene is toxic, then the level of 
bacteriophage T7 RNA polymerase must be kept low during cell growth. One way to 
accomplish this is to use the lysogen BL2I(DE3), in which bacteriophage T7 gene 1 is 
expressed from the LacUV5 promoter, such thatit is inducible by IPTG. 
To allow the synthesis of the HMG box in E. coli, these primers where also designed 
in order to change valine 4 (see figure 1) to methionine, to provide a translation start 
site. Also lysine 77 was changed to a stop codon. DNAs from PCRs were then 
digested with restriction endonucleases Na! and HindIII, loaded on an agarose gel, 
gel purified and cloned between the NdeI and Hind!!! sites of plasmid pT7-7. The 
resulting plasmids were then introduced in strain BL21(DE3), a host strain containing 
an IPTG inducible gene for T7 RNA Polymerase. Plasmid DNA from positive 
colonies was extracted and checked by sequencing with T7 DNA polymerase (see 
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Fig. 1. Alignment of HMG boxes. Only proteins mentioned in the main text are 
shown, a more exhaustive compilation may be found in Bianchi et al: (1992a). The 
first group of HMG boxes are from chromatin proteins. HMGI proteins of mammals 
have two HMG boxes and are identical save conservative substitutions in the C- 
terminal acidic stretch (not shown here): plant, protozoan and yeast HMG I-tike 
proteins contain a single HMG box. The second group of HMG boxes are from 
general transcription factors for RNA polymerise I (human UBF, with four boxes) 
and mitochondrial RNA polymerases (human mtTFI, with two boxes). The third 
group of H1VIG boxes are from transcriptional regulators. Dashes indicate gaps in the 
alignment: Z indicates a stop codon in the gene. The consensus sequence for the 
1-IMG box motif was obtained from 21 protein sequences: one-letter symbols indicate 
amino acids present in 50-90% of the sequences: conservative substitutions (at least 
75% of the occurrences at a particular position) are indicated as follows: (c for 
proline, alanine, glycine, serine and threonine: % for tryptophan, phenylalanine and 
tyrosine: $ for methionine. valine, leucine and isoleucine. The numbering system starts 
from the first conserved proline and is based on FLN(IG I box A. 
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materials and methods). Bacterial cells containing the right constructs were grown up 
to O. D. 600=0.6 and then T7 protein expression was induced by IPTG for two hours. 
Part of the E. coli extract was boiled in a denaturing loading buffer (Laemmli buffer) 
and separated on SDS PAGE to verify if corresponding polypeptides were expressed 
at high levels in E. coll. The majority of the bacterial pellet was resuspended in a 
sonication buffer, sonicated until clarification, treated with DEAE cellulose to remove 
nucleic acids and then centrifuged. The supernatant containing the soluble 
recombinant protein was filtered through a cache of glass wool, applied to a Mono S 
FPLC column. This column is a strong cation exchanger with charged sulfonic groups 
which remain negative over the pH range 2-12; it was used because wt and mutated 
hSRY boxes have a high content of basic residues. Fractions were then analysed on 
SDS PAGE, and also monitored with absorbance. Purified proteins were eluted in 
fractions containing 1M NaCI (see Materials and Methods). Proteins were 99% pure 
(figure 2). 
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Fig. 2. Purification of E. coli HMGboxes. 
Proteins were purified by removing most E. coli proteins by precipitation with 
ammonium sulphate, and fractionation of the resulting supernatant by chromatography 
(see Materials and Methods). 
Aliquots from the mono S fractions were mixed with I p. g of BSA. to serve as an 
internal quantity standard. When electrophoresed on SDS phage. a single band with 
an apparent molecular mass of about 9 Kd appears in fraction 3 and 9. Molecular 
mass standards are shown in lane M. 
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2.2 THE AFFINITY OF WT AND MUTANT BOXES FOR BENT DNAS 
The HMG box domains of HMG1 (an abundant chromatin protein) and UBF (a 
general transcription factor for RNA polymerase I) all recognise four-way junctions 
structure-specifically and sequence-independently (Bianchi et al., 1992a, 1992b; Kuhn 
et al., 1994). The recognition of this unusual DNA structure is related to the 
functional properties of this class of proteins (Lilley, 1992), and depends on the 
structural integrity and correct folding of the HMG box domain (Falciola et al., 1994). 
To find evidence for a possible role of the stability of DNA-protein complex of the 
HMG boxes of SRY in gene expression and sex determination, we tried to compare 
their affinities for DNA. 
Binding specificity and affinity of the normal and the five purified mutant HMG boxes 
(hSRY boxes) for a bent DNA fragment were determined in band shift assays using a 
limiting amount of labelled DNA and titrating the polypeptides (see below and 
Materials and Methods). 
The gel shift assay is one of the most powerful methods for the analysis of DNA- 
protein interactions. The assay itself is simple; DNA and protein are mixed together, 
the solution subjected to vertical electrophoresis through polyacrylamide gel, and the 
gel is then analysed for DNA, usually by autoradiography of radiolabeled DNA. 
Binding of the protein to the DNA can result in a complex that has a different 
electrophoretic mobility from the free DNA. In general, the mobility of the complex is 
retarded relative to the unbound DNA and thus the assay is often called gel 
retardation. The separation of the complex from the free DNA, and therefore the 
detection of the complex, is dependent on a variety of factors. Factors that influence 
the electrophoretic mobility of DNA-protein complexes include the molecular weight 
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of the protein and the DNA, the ionic strength and the pH of electrophoresis buffer, 
the concentration of the gel matrix and the temperature. The principle of the gel shift 
assay is that the entry of the mixture of free DNA and DNA-protein complex into the 
gel matrix results in the physical separation of the two species. In the subsequent 
electrophoresis, the protein generally makes no difference to the mobility of the free 
DNA, although it has been shown that complexes reversibly dissociate and reassociate 
within the gel. However, even if the bound DNA dissociates from the protein during 
electrophoresis, it can never "catch up" with the DNA that was free at the start of the 
run. The concentration of each species can then be determined. Assays of this type 
can yield the equilibrium constant for the binding of the protein to its DNA ligand and 
also the kinetics of the interaction. 
With this technique, mutated and wt hSRY proteins were demonstrated to recognize 
with high affinity bent DNA, irrespective of its sequence. A probe with bent DNA 
structure was obtained by annealing four appropriately chosen oligonucleotide 
sequences. In this way molecules were generated with the shape of cruciform 
(cruciform c), similar to those of Holiday junctions (Fig. 3). Cruciform DNA was 
labelled with 32P and gel purified; wt and mutated SRY boxes were then incubated 
with labelled junction probe c and samples were applied to vertical polyacrylamide 
gels. Gels were electrophoresed, dried and autoradiographed for 16 hours. 
All hSRY boxes formed well defined complexes with the four-way junction probe c. 
Figure 4 shows the band shift experiment obtained with wt hSRY box. About 0.5 ng 
of peptide hSRY box (lanes 1-4) or control buffer with no protein (lane 5) were mixed 
in standard binding buffer with various concentrations of four-way junction DNA c, 
and assayed by gel electrophoresis as described before. Wt hSRY box forms well 




Design of an artificial cruciform DNA. 
The molecule c, unlike natural cruciform DNA, has no sequence symmetry and cannot 
dissociate through branch migration. Cruciform DNA molecules were produced by 
annealing chemically synthesised oligonucleotides 1,2,3, and 4. 
I: CCCT. -ATAACCCCTGCATTGAATTCCAGTCTGATAA 
2 GT. AGTCGTGAT. -kGGTGC.. \GGGGTTATAGGG 
3 AAC. AGTTAGCTCTT. -ATTCGAGCTCGCGCCCTATCACGACTA 
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Fib. 4 Peptide hSRY box recognises the four-way junction DNA c. About 05 
nanograrns of peptide hSRYbox (lanes I to 4) or control buffer with no protein (lanes 
5) were mixed in standard binding buffer with various concentrations of four-way 
junction DNA c, and assayed by gel electrophoresis as described in Materials and 
methods. The concentration of DNA was as follows lanes I, 1.5 nM, lanes 2. S nM: 
lanes 3,40 nM; lanes 4 and 5,200 nM. 
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formed by wt hSRY box probably contain multiple copies of polypeptide per DNA 
molecule, some bound to the high affinity sites at the base of the junction and some to 
low affinity sites on the arms of the junctions. 
In similar band shift assays mutant SRY boxes were shown to recognise four-way 
junction probe c with the same affinity as the wt protein and the same multiple 
retarded bands at high protein to DNA ratios were observed. 
To obtain convincing proof that wt and mutated hSRY boxes recognise the peculiar 
shape of four-way junctions, and not sequence-specific binding sites adventitiously 
present in the junction, binding affinities of wt and mutant SRY boxes for linear and 
junction DNA were examined in more detail by means of additional band shift assays. 
In this experiment another type of junction (z) was used, which contains sequences 
deliberately chosen as poor binding sites for SRY (Harley et al., 1992). Cruciforms c 
and z have different sequences but share the same bent structure. 
Control DNAs were obtained by synthesising linear duplex DNAs containing the same 
sequence of the arms of cruciform z (az and bz) but they will have a different shape 
(figure 5). These molecules do not have angles distorting the axis of the DNA. 
Although the artificial cruciform z has no obvious sequence similarity with cruciform 
c, it is recognised in the same way by wt and mutated SRY boxes. Control linear 
duplex DNA (az and bz) which contains the same sequence as cruciform DNA but a 
different structure are not recognised with high affinity by these proteins. Figure 6 
shows the band shift assay performed with wt hSRY box and probe junction z, versus 
linear duplex arms az and bz. Labelled junction z, duplex az and bz were mixed in 10 
microliters of standard binding buffer with the identical amounts of wt hSRY box 
peptide. Samples were applied to a vertical 6.5 polyacrylamide gel and elecrophoresed 


























Fig. 5 Design of an artificial cruciform DNA. 
The molecule z, unlike natural cruciform DNA, has no sequence symmetry and cannot 
dissociate through branch migration. Cruciforms z and c have no obvious sequence 
similarity, but are both recognised by SRY box. Cruciform and linear duplex DNA 
molecules were produced by annealing chemically synthesised oligonucleotides. 
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Fig. 6. Peptide hSRYbox does not recognize linear control DNAs az and bz at the 
concentrations optimal for complex formation with junction z. Labeled junction z, 
duplex az and bz (0.2 mM) were mixed in 10 µl of standard binding buffer with the 
indicated amounts of hSRYbox peptide. Electrophoresis and auto radiography were 
done as described in materials and methods. 
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Peptide wt hSRY box does not recognise linear control DNAs az and bz at the 
concentrations optimal for complex formation with junction z. The identical result was 
obtained by performing the same experiment with all mutated SRY boxes associated 
with sex reversal phenotypes. 
To investigate in more detail if various single point mutations associated with sex 
reversal phenotype could slightly affect the binding affinity of a bent DNA, constants 
of dissociation of the DNA-SRYs complexes were measured and compared. 
Band shift assays are ideal for equilibrium studies, because bound DNA can rapidly 
separate from free DNA. DNA retained by the protein can be easily quantified and 
compared with free DNA. The protein DNA binding interaction can be looked at as 
an equilibrium represented by the equation: 
[PDI=[ ]+[Dl, 
so that Keq = [P][D]/[PD] 
where [P]= concentration of total protein. It corresponds to the concentration of free 
protein if the concentration of protein bound to DNA is very low; this is possible 
when the concentration of total DNA is«[P]. 
[D]= concentration of free DNA 
[PD]= concentration of protein DNA-DNA complex. 
Keq= equilibrium dissociation constant (in this case referred as the dissociation 
constant, Kd). 
The Kd of a given protein-DNA interaction is a measure of the affinity of the protein 
for that particular piece of DNA. The apparent Kd can be determined by a band shift 
assay in which protein is titrated against a known amount of DNA containing the 
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binding structure or site being tested. The half -maximal point of the resulting curve is 
equal to the Kd, since at the 50% saturation of the DNA, [PD]=[D]. 
Therefore, the equation 
Keq=Kd= [P][D]/[PD] is reduced to Kd=[P]. 
This simplification is true only if [D]«Kd. 
Therefore, as in our case, the amount of DNA used in these experiments in usually 
very small. 
This basic algebra means that in a band shift assay, under conditions of protein excess, 
the dissociation constant is equivalent to the concentration of polypeptide when half 
of the input DNA is taken up in the complexes and half is free. 
All mutant SRY boxes were then individually titrated and analysed in a band shift 
assays, with four way junction probe z. 
The affinities of the mutant SRY DNA binding domains towards junction z were 
indistinguishable from that of the wild type domain (Table 1). From these 
observations we can conclude that the various proteins were all equally active towards 
these DNA molecules, indicating that the amount of inactive polypeptide chains was 













Fib. 7 DNA binding properties of some hSRYboxes. 
DNA binding mixtures were set up to contain 1.5 nNI labelled four way junction DNA 
z. Each panel contains the following amounts of the indicated peptides: lanes 1, no 
protein, lanes 2,5 OvI, lanes 3,10 nil, lanes 4,20 nMVl. Samples were assayed by 
electrophoresis as described in materials and methods. The faster migrating band is 
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Table 1. SRY mutations characteristics and properties of the bent DNA-SRY boxes 
interaction. The mutations in SRY we have considered were described by Berta et al. 
(1990), Hawkins et al. (1992a, b) and Jager et al. (1992). The dissociation constants 
for complexes between the various SRY boxes and DNA were calculated by titrating 
the SRY box polypeptides against 0.25 M DNA and assaying the formation of 
complexes by electrophoretic mobility shift assays. "Four-way junction" refers to 
junction molecule z, which was chosen because the sequences it contains cannot be 
recognised sequence-specifically by SRY protein (Ferrari et al.. 1992). The reported 
values are the mean of at least two assays. 
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2.3 THE DNA-BENDING ACTIVITY OF NORMAL AND MUTANT SRY 
BOXES 
The results described in the previous sections establish that hSRY boxes can bind 
efficiently to structurally similar targets where the DNA is strongly distorted. 
It was previously shown that wt hSRY recognises a double stranded DNA consensus 
site and induces a distortion in the axis of the molecule. To test if single point 
mutations in hSRY box, associated with sex reversed phenotype, can modify the 
geometry of the DNA-protein complex, we performed a circular permutation assay to 
detect any large distortions induced in linear DNA. DNA fragments with a distortion 
in the middle of the molecule have a different shape, and hence different 
electrophoretic mobility, compared to DNA fragments of identical length and 
composition with a distortion near one end (Wu and Crothers, 1984). The bending 
angle alpha is defined as the angle by which a segment of the rod like DNA duplex 
departs from linearity. It is possible to estimate alpha by measuring the mobility of the 
complex with the protein bound at the middle of the fragment and the mobility of the 
complex with the protein bound near the end of the DNA fragment using the 
relationship reported in Materials and Methods. 
Although the relationship between electrophoretic mobility and conformation is 
complex (Levene and Zimm, 1989), the algebra allows one to map the locus of 
protein-DNA interaction and to estimate the amount of distortion introduced in DNA 
simply by measuring the rate of migration in polyacrylamide gels of complexes of 
protein with DNA fragments of circularity permuted sequence (Liu-Johnson et al., 
1986; Thompson and Landy, 1988; also see Materials and Methods). 
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To generate the probes for the permutation assay, a short sequence from the enhancer 
of the CD3e gene, containing the AACAAAG sequence and previously shown to be a 
good binding site for human SRY protein (Harley et al., 1992), was cloned between 
two directly repeated sequences in plasmid pBend2. These two duplicated circular 
permuted sequences contain the same set of 17 cloning sites for insertion of protein 
binding sequences (figure 8). The duplicated sites can be used to generate DNA 
fragments of identical length, but in which the protein binding sequence is shifted. 
Sites Xbal and Sall are unique, in the middle of the tandemly repeated sequences and 
suitable for the cloning of the protein binding sequence. 
Briefly, to subclone the CD3 epsilon site in the vector, synthetic oligonucleotides 
CTAGAGAGCGCTTTGTTCTCAG and TCGACTGAGAACAAAGCGCTCT were 
annealed, generating a double stranded molecule containing sticky ends cmplementary 
to the overhangs produced by cutting with restriction endonucleases Xbal and Sall. 
This molecule was subcloned within the Xbal and SaII sites of the vector p Bend 2; 
the recombinant vector was checked by sequencing and digested with the set of 
restriction enzymes reported in figure (8). Cleavage with restriction endonucleases 
indicated in the map of fig. 8 yielded a set of fragments of DNA (designated A-G) 
containing circular permutations of the same sequence of 141 b. p. These molecules 
therfore have identical lengths, the same sequences but each has a different distance 
from the binding site and the ends of the molecule (circular permuted sequences). 
Circular permuted fragments were gel purified and the same amount of DNA was 
labelled with 32P (see material and methods) and incubated with purified wt and 
mutated SRY boxes. Samples were applied to a polyacrylamide gel and the 
electrophoretic mobility of the resulting complexes were analysed. Figure 9 shows the 
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Fig. 8 Circular permuted probes. Plasmid pB2CD3e, containing the CD3e site 
(stippled box) flanked by tandemly duplicated DNA sequences, was cleaved at the 
restriction sites indicated in the map. The DNA fragments obtained in this way 
(designated A to G) all contain circular permutations of the same sequence of 141 bp 
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Fig. 9. Circular permutation analysis of DNA flexure induced by binding of human 
SRY to the AACAAAG sequence. A. Electrophoretic mobility of the circularly 
permuted DNA fragments complexed to the human SRY protein. DNA fragments A 
to G (Fig 6,8 femtomoles) were mixed with sonicated salmon sperm DNA (50 n`; ) in 
9 µI of standard DNA binding buffer (see Materials and methods). To the various 
mixtures we added l µl of purified fraction (about 5 ng of protein) containing human 
SRY, or the same volume of water. Electrophoresis and autoradiography were 
performed as indicated in materials and methods. B. Mapping of the locus of flexure 
and analysis of the bending parameters. The mobilities of the protein-DNA complexes 
(Rbound) were normalized to the mobility of the corresponding free DNA (Rfree). 
The distance of the center of the CD3e site from the 5' end of the probe was divided 
by the total length of the probe (flexure displacement). The plotted points were 
interpolated with a quadratic function as described in materials and methods. The 
fitting second-order equation was y=1.117x2 - 1.13 Ix + 0. SO4 (R2 = 0.097). The 
first and second-order parameters of the equation are in close agreement and yield an 
estimate of deviation from linearity of about 83". The locus of flexure was localized to 
the center of the AACAAAG sequence, ±2 bp. 
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human SRY box. The formation of complexes was dependent on the presence of SRY 
proteins. DNA-protein complexes with the CD3e binding site in the middle (fragment 
D) migrated significantly slower than complexes with the site near the ends (fragments 
A and G). No statistically significant difference in the mobility of the free DNA probes 
was observed, indicating that the CD3e site does not distort DNA on its own. By 
analysing the data in terms of a simple geometric model (see legend of figure 9 and 
Materials and Methods), the locus of flexure was localised to the center of the 
AACAAAG site. 
We then compared the different mobilities of the nucleoprotein complexes of mutated 
SRY boxes and the angles they induced on target DNA. Figure 10 shows a 
comparison between the electrophoretic mobilities of complexes of wild type hSRY 
box and mutant F109S (panel B), mutant M641 (panel C) and mutant K1061 (panel D) 
with probes A-G containing the CD3e site GAACAAAG. Briefly, 3 fmol of labelled 
DNA probes were mixed in 9 µl of standard DNA binding buffer (see Materials and 
Methods). To the various mixtures 1 [d of purified protein was added (2 ng of 
hSRYbox wild type, 2 ng of hSRYbox F109S, 10 ng of hSRYbox M64I, 25 ng of 
hSRYbox K106I). Electrophoresis and autoradiography were performed as indicated 
in Materials and Methods; however, the autoradiography in panel D was overexposed 
to detect the faint bands of DNA complexed to hSRYbox K1061. The retarded bands 
running behind the principal protein-DNA complex band are complexes containing 
more than one polypeptide molecule per DNA molecule. No significant difference in 
the mobility of the free DNA probes can be observed, indicating that the CD3e site 
does not distort DNA on its own. By analysing the data in terms of a simple geometric 
model (see Materials and Methods), it appears that the mutant SRY boxes also flex 
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Mutation Type KD Angle Kd four way 
linear DNA junc. DNA 
WT 






2x10.8 M 760 
2.5x10 -8 M 
4x10 -8 M 







10 -8 M 
10 -8 M 
10 -8 M 
10 -8 M 
10 -8 M 
10 -8 M 
Table 2. Summary of SRY mutation characteristics and properties of the SRY boxes. 
The mutations in SRY we have considered were described by Berta et al. (1990), 
Hawkins et al. (1992a, b) and Jager et al. (1992). The dissociation constants for 
complexes between the various SRY boxes and DNA were calculated by titrating the 
SRY box polypeptides against 0.25 nM DNA and assaying the formation of 
complexes by electrophoretic mobility shift assays (see materials and methods). 
"Linear" refers to the D probe bearing the CD3e site, "four-way junction" refers to 
junction molecule z, which was chosen because the sequences it contains cannot be 
recognised sequence-specifically by SRY protein (Ferrari et al., 1992). "Angle" refers 
to the angle calculated by the algorithm of Ferrari et al. (1992) from the' circular 
permutation assays on the set of probes bearing the CD3e site. The reported values 
are the mean of at least two assays. 
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Fig. 10 A and B. DNA bending activity of mutant SRY E-L M[G-boxes on the CD3e 
sequence. (A) DNA probes used for the circular permutation analysis. Plasmid 
pBend2CD3e, containing the CD3e site (hatched box) flanked by tandemiv repeated 
DNA sequences, was cleaved at the restriction sites indicated in the map The DNA 
fragments obtained in this way (designated A-G) all contain circular permutations of 
the same sequence of 141 bp. DNA fragments containing CD3e sequence, designated 
MUTI I, were `(venerated in the same way (B) Circular permutation analysis of DNA 
bending induced by mutant hSRY box F 109S. This panel shows a comparison 
between the electrophoretic mobilities of complexes of wild type hSRYbox and 
mutant F 109S with probes A-G containing the CD3e site GAACAAAG. Three fnol 
of labelled DNA probes were mixed in 9 ul of standard DNA binding butler (see 
Experimental Procedures). To the various mixtures I µl of purified protein was added 
ng of hSRYbox wild type and 2 ng of hSRYbox F IO9S). Electrophoresis and 
autoradiography were performed as indicated in material and methods The retarded 
bands running behind the principal protein-DNA complex band are complexes 
containing more than one polypeptide molecule per DNA molecule. No signiticant 
difference in the mobility of the free DNA probes can be observed, indicating that the 
CD3e site does not distort DNA on its own. 
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Fig. lO A and C. DNA bending activity of mutant SRY I-GV[G-boxes on the CD3e 
sequence. (A) DNA probes used for the circular permutation analysis. Plasmid 
pBend? CD3e, containing the CD3e site (hatched box) Clanked by tandemly repeated 
DNA sequences, was cleaved at the restriction sites indicated in the map The DNA 
t'ragments obtained in this way (designated A-G) all contain circular permutations of 
the same sequence of 141 bp. DNA fragments containing CD3e sequence, designated 
, MUTI I, were generated in the same way. (C) Circular permutation analysis of DNA 
bending induced by mutant hSRY box Mo41. This panel shows a comparison between 
the electrophoretic mobilities of complexes of wild type hSRYbox and mutant \16-11 
with probes A-G containing the CD3e site GAACAAAG. Three fmol of labelled DNA 
probes were mixed in 0 ul of standard DNA binding buffer (see Experimental 
Procedures). To the various mixtures I ul of purified protein was added (2 ng of 
hSRY box wild type and IO ng of hSRY box X164[). Electrophoresis and 
autoradiographv were performed as indicated in materials and methods. The retarded 
bands running behind the principal protein-DNA complex band are complexes 
containing more than one polvpeptide molecule per DNA molecule. No significant 
difference in the mobility of the free DNA probes can be observed, indicating that the 
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Fig. 10 A and D. DNA bending activity of mutant SRY FD, [G-boxes on the CD3e 
sequence. (A) DNA probes used for the circular permutation analysis. Plasmid 
pBend2CD3e, containing the CD3e site (hatched box) flanked by tandemly repeated 
DNA sequences, was cleaved at the restriction sites indicated in the map. The DNA 
fragments obtained in this way (designated A-G) all contain circular permutations of 
the same sequence of 141 bp. DNA fragments containing CD3e sequence, designated 
MUT II, were generated in the same way. (D) Circular permutation analysis of DNA 
bending induced by mutant hSRY box K106[. This panel shows a comparison 
between the electrophoretic mobilities of complexes of wild type hSRYbox and 
mutant K1061 with probes A-G containing the CD3e site GAACA. -AAG Three tinol 
of labelled DNA probes were mixed in I) pi of standard DNA binding butter (see 
Experimental Procedures). To the various mixtures I µl of purified protein was added 
(2 ng of hSRY box wild type and 25 nu of hSRYbox K 1061). Electrophoresis and 
auto radiography were performed as indicated in Experimental Procedures, however, 
the autoradiography in panel D was overexposed to detect the faint bands of DNA 
complexed to hSRY box K1061. The retarded bands running behind the principal 
protein-DNA complex band are complexes containing more than one polypeptide 
molecule per DNA molecule. No significant difference in the mobility of the tree DNA 
probes can be observed, indicating, that the CD3e site does not distort DNA on its 
own 
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the DNA in the centre of the AACAAAG site. Table 2 summarises results from 
circular permutation assays obtained with the complete set of mutated SRY boxes. 
Wild type SRY box bends the DNA at CD3e site by an angle of 75 degrees, while 
mutant M641 induces a significantly smaller angle, of about 56°. All other mutants, 
including K106I, bend the DNA by an angle extremely close to the wild type protein 
(Table 2 and figure 10). 
To investigate the possible relationships between binding affinity and bending 
capability of SRY mutants, the affinities of the normal and the five mutant HMG 
boxes for a DNA fragment containing the CD3e enhancer site were determined in 
band shift assays using a limiting amount of labelled DNA and titrating the 
polypeptides. As described before, under conditions of protein excess, the dissociation 
constant is equivalent to the concentration of polypeptide where half of the imput 
DNA is taken up in the complexes and half is free. 
Mutant HMG boxes varied extensively in their DNA binding ability, in accordance 
with a previous report (Harley et al., 1992). The affinity for DNA of mutant F109S 
was indistinguishable from that of the wild type, as already noted by Jager et al. 
(1992). The affinity of mutants 190M and M641 was moderately reduced in 
comparison to the wild type, whereas the affinity of K106I was reduced by more than 
two orders of magnitude, and G95R did not form any complexes under the conditions 
used (Table 2). Variations of activity in a bandshift assay can be caused by a variation 
in the intrinsic affinity of the proteins for DNA, or by the presence of a variable 
proportion of denatured or inactive protein molecules in the preparation. To rule out 
the latter alternative, we tested the DNA binding activity of various preparations of 
the same polypeptide, and found them identical. 
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Our results indicate clearly that mutant M641 bends the DNA much less than the wild 
type, but its binding affinity is reduced only mildly, whereas mutant K1061 bends the 
DNA almost as much as the wild type, although its DNA binding affinity is reduced by 
more than two orders of magnitude. Thus, contrary to a widely held preconception, 
affinity and DNA bending are not correlated, and a weakly binding protein can 
produce a large DNA distortion. 
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2.4 WILD TYPE SRY AND THE M641 MUTANT RECOGNISE THE SAME 
REPERTOIRE OF SEQUENCES IN LINEAR DNA 
The difference in the angle induced by mutant M641, viewed against the relative 
uniformity of the other mutants, appears as quite large. In comparison, the DNA 
bending properties of SRY proteins from mutations associated with a mild biological 
effect are strictly conserved. Thus, it is tempting to consider the difference in bending 
ability of the M641 mutant as a key to the biological consequences of the mutation. A 
more trivial explanation is possible, however: mutation M641 might modify the 
sequence specificity of SRY protein. In order to test this hypothesis, we performed an 
experiment of PCR-assisted binding site selection. Binding-site selection is used to 
determine the target specificity of a sequence-specific DNA-binding protein. The 
technique has a number of applications, for example to identify DNA target sequences 
for proteins with unknown DNA-binding specificities to or to provide additional 
information on the protein-DNA interactions of previously characterised DNA binding 
domains. 
As indicated in Materials and Methods, a pool of random-sequence oligonucleotides is 
used as the source of potential binding sites. The oligonucleotide pool is made double 
stranded and labelled with 32P dCTP. Several cycles of selection and amplification of 
a random population of double-stranded DNA are performed. The starting population 
consists of a family of double stranded 60 bp DNA molecules initially displaying all 
possible sequence variations at the central 10 nucleotide residues. Flanking regions are 
25 base pairs long and constant in sequence. Two EcoRI restriction sites were present 
in the two constant regions flanking the 10 bp central random sequence. The starting 
population of molecules was labelled with 32P and then incubated with different 
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amounts of M641 hSRY box protein. Samples were applied on a vertical 
polyacrilamyde gel and electrophoresed at room temperature. The shifted band, 
containing a subset of the original population of labelled molecules, was recovered by 
cutting out a gel slice, crushing it and eluting the DNA. The eluted DNA was 
amplified by PCR, using dCTP labelled with 32P. The radioactive product was gel 
purified, incubated again with M641 hSRY box and electrophoresed as described. 
Shifted band was recovered, eluted, amplified and incubated again as described 
before. Five rounds of selection/amplification were sufficient to select a population 
with maximal affinity for the protein. Additional cycles of selection/amplification did 
not increase the average affinity of the population for the protein. Selected molecules 
were digested with EcoRI, gel purified and subcloned in the Eco RI site of the vector 
pUC19. Bacteria carrying recombinant plasmids give rise to white colonies. White 
colonies were then picked at random; plasmids were extracted and selected molecules 
were sequenced (figure 11). These sequences can be aligned, are rich in A's and T's 
and the distribution of bases at seven individual positions is clearly non random. The 
consensus that can be derived matches exactly the consensus determined for 
molecules selected in selection/amplification protocol by wild type SRY protein, A/T 
AACAA A/T (Harley et al., 1994). 
We also compared the binding preferences of both mutant M641 and wild type SRY 
boxes with respect to the entire repertoires of sequences, rather than individual 
sequences. A competition between the initial (non-specific) and final (specific) 
population of DNA molecules was performed (figure 12). Labelled templates selected 
by M641 hSRY protein were purified and amplified after the first round of selection 
(first round) and after the fifth round (last round). These two families of probes were 
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Fig II The HMG boxes of wt SRY and mutant M641 recognise the same repertoire 
of sites. Sequence of some DNA molecules selected after the fifth 
selection/amplification cycle with SRY HMG-box M641. Sequences were alined 
following the algorithm of the program "Align". The lower-case bases belong to, the 
polylinker of plasmid . 
The frequency of each base at each position is indicated below 
the sample set of sequences. This consensus that can be derived matches the 











Fig. 12. Wt SRY box and mutant M64 recognise the same repertoire of sites. A 
population of 60 bp DNA molecules initially containing all possible 10 bp sequences 
at their centre was subjected to five rounds of selection/amplification by SRY box 
M641 (see materials and methods). At the end of the procedure, labelled templates 
amplified after the first round of selection by hSRY box M64I (first round) and after 
the fifth and last round were mixed in different ratios, mixed with wt SRY box or 
M64I SRY box, and electrophoresed. The same total amount of DNA (21 fmol) was 
used as probe in every lane (last round/first round: 0/21,3/18,7/14,10.5110.5,14/7, 
18/3, and 21/0). To 9 tl of reaction mix containing the DNA probes, 20 ng of hSRY 
box M641 (panel above, right) or 5 no of hSRY box wt (panel above, left) were 
added. After incubation on ice, samples were applied to vertical 6.5% polyacrvlarnide 
gels in 0. SX TBE as described in materials and methods. As expected, the population 
of DNA molecules amplified after the fifth round of selection/amplification with the 
mutant SRY box M641 are recognised much better by mutant M641 than the initial 
population. However, the same is true if the populations are challenged with the vvt 
SRY box. Mixing the initial and final populations in different proportions is equivalent 
to performing a competition experiment between a specific binding site and aspecific 
DNA. As the figure shows, again no difference is apparent between the bandshifts 
produced by the wt SRY box and mutant \1641, an indication that their binding 
selectivity is the same 
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proportions is equivalent to performing a competition experiment between a specific 
binding site and non specific DNA. The same amount of DNA was used as a probe in 
every lane and incubated with wt hSRY box or M641 hSRYbox and elecrophoresed. 
As expected, the population of DNA molecules amplified after the fifth round of 
selection/amplification with the mutant M641 SRY box are recognised much better by 
mutant M641 than the initial population. However, the same is true if the populations 
are challenged with the wt SRY box (figure 10). As figure 12 shows, again no 
difference is apparent between the bandshifts produced by the wt SRY box and 
mutant M641, an indication that their binding selectivity is the same. Similar results 
were also obtained using defined sequences rather than populations. We conclude that 
the mutant M641 and the wild type SRY boxes recognise the same sites, and that each 
specific "preferred" sequence is recognised with similar specificity over 
"nonpreferred" sequences. 
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2.5 DNA SEQUENCE AFFECTS DNA BENDING BY SRY 
The experiments reported in the previous sections establish that one specific DNA 
sequence is molded into different configurations by mutant M641 and by the wild type 
SRY. However, there is no guarantee that the CD3e site is a true SRY binding site; in 
fact, a physiological target for SRY has not been identified so far. Moreover, the 
DNA itself is possibly the major determinant in the final conformation of the 
nucleoprotein complex, and slight variations of the DNA sequence interacting with 
SRY might affect the geometry of the nucleoprotein complex quite substantially. We 
then measured by means of the circular permutation assay the angle of deflection 
produced by wild type and mutant SRY proteins on two sequences that diverge 
slightly from the CD3e sequence. 
The sequence TAACAATG (MUT 11) has been reported to bind SRY protein with 
higher affinity than the GAACAAAG sequence present in the enhancer of the CD3e 
gene, while the sequence GAACACAG (MUTO) was reported to be a poorer binding 
site (Giese et al., 1992). The two sequences were substituted for the CD3e sequence 
in plasmid pBendCD3e. This was obtained by annealing synthetic oligonucleotides 
CTAGAGAGCGCATTGTTATCAG and TCGACTGATAACAATGCGCTCT for 
MUT 11, CTAGAGAGCGCTGTGTTCTCAG and 
TCGACTGAGAACACAGCGCTCT for MUTO. Double stranded molecules contain 
sticky ends for restriction endonucleases XbaI and Sall. 
These molecules were subcloned within the sites Xbal/Sall of the vector pBend2; 
recombinant vectors were checked by sequencing. Cleavage with several restriction 
endonucleases yields a set of fragments of DNA of identical length and sequence, but 
a different distance from the DNA binding domain and the edges of the molecules. 
47 
The circularly permuted fragments obtained from the two new plasmids (called 
pBendmutl1 and pBendmut0, respectively) were purified from agarose gels, labelled 
and tested electrophoretically with wild type and mutant hSRY boxes for binding 
affinity and bending features (Table 3 and figure 13), in the same way as described 
before. 
The fragments bearing the sequence TAACAATG bound every hSRY box variant 
with about twofold better affinity than the GAACAAAG sequence. The circular 
permutation assay showed that the locus of flexure was the same as for pBendCD3e 
fragments, but the bending was slightly less. 
The fragments bearing the sequence GAACACAG bound every SRY HMG-box 
variant about six fold less efficiently than the pBendCD3e fragments. Again, the 
protein-induced bending was centered around the same locus, showing that the 
GAACACAG sequence was preferred to any other sequence in the probe. However, 
the bending was dramatically reduced with the wild type SRY box, while mutant 




Probe Sequence KD Angle KD Angle 
CD3e GAACAAAG 2x10-8 M 76 6.5x10-8 M 56 
mut lI TAACAATG 10-8 M 73 3x10-8 M 55 
mutO GAACACAG 10-7 M 35 3.5x10-7 M <10 
Table 3. Influence of the DNA sequence on the amplitude of the angle induced by 
SRY proteins. The dissociation constants for complexes between SRY boxes and 
DNA were calculated by titrating the SRY box polypeptides against 0.25 nM DNA 
and assaying the formation of complexes by electrophoretic mobility shift assays (see 
material and methods). "Angle" refers to the angle calculated by the algorithm from 
the circular permutation assays on the set of probes bearing the CD3e site. The 
reported values are the mean of at least two assays. 
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Fig. 13. DNA binding sites with different sequences are bent differently by SRY 
boxes. (A) Mobility shift assay of wild type and mutant SRY boxes on CD3e (e) and 
mutt I (11) binding sites. Probe D was used because it contains the DNA binding site 
(CD3e or mut 1 1) in the middle of the fragment and the differences in electrophoretic 
mobilities are maximal. DNA binding mixtures (see materials and methods) were set 
up to contain 3 fmol of CD3e D probe or mut lID probe in 9 ul. To each mixture 
containing the CD3e D probe, l ul of purified protein was added, containing 50 nix of 
hSRY box of G95R, 3 ng of hSRY box wild type, 10 no, of hSRY box 190M. 15 n`; of 
hSRY box M641,25 ng of hSRY box K1061, respectively. About a quarter as much 
wild type hSRY box and half as much for each mutant SRY box were added to 
mixtures containing the mut lID probe. Autoradiographic signals were also analysed 
with a Phosphortmager No binding activity was found for hSRY box G95R. The 
same results were obtained also when using larger amounts of purified hSRY" box 
G95R protein. (B, C) Circular permutation analysis of wild type hSRY box (panel B) 
and mutant 164[ (panel C) on CD3e and mutö binding sites. DNA probes A-G (3 
fmol) were mixed in 9 ul of standard DNA binding buffer (see materials and 
methods) To the various mixtures containing labelled DNA fragments I ul of purified 
protein solution was added. containing 2 no, of hSRY box wild type (probe CD3e), b 
n`, of hSRYbox wild type (probe mutO). 15 ng of hSRY box M64l (probe CD3e), 60 
m, of hSRY box i\, 1641 (probe mut0) The samples were electrophoresed and 
autoradiographed as described in materials and methods The retarded hands running 
behind the principal protein-DNA complex band are complexes containing more than 
one polvpeptide molecule per DNA molecule Unbound DNA probes containing mutO 
site have the same electrophoretic mobility, indicating that the mut0 site. as well as 
the CD3e site, does not distort DNA on its own. 
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2.6 THE POSITIVE CONTROL: THE EVOLUTIONARY TREE OF 
PRIMATES. 
In the first part of this work, anomalous DNA protein complexes were shown to be 
correlated to anomalous biological function of SRY protein. 
Indeed all single point mutations in the human SRY coding sequence that cause 
gonadal dysgenesis and sex reversal fall in the HMG box region (Berta et al., 1990; 
Hawkins et al., 1992 and 1994). In addition, the HMG box is the only part of SRY 
which is conserved during the evolution of mammals: the protein segments flanking 
the HMG box are variable in sequence and length and cannot be aligned exept 
between closely related species (see introduction). All the DNA binding and bending 
activity resides in the HMG box region. If binding and bending are really important for 
the biological function of SRY proteins, these features will be expected to be 
positively selected and conserved during evolution. The purpose of the second part of 
this work is then to demonstrate that the architecture and stability of nucleoprotein 
complexes formed by the DNA-binding domains of SRY proteins is of primary 
importance and therefore conserved irrespective of the time of divergence during 
primate evolution and the number of residues modified during this evolution. 
49 
2.7 PRODUCTION OF SRY DNA BINDING DOMAINS OF DIFFERENT 
PRIMATES. 
We first chose to compare SRY HMG boxes (SRY boxes) of different primates on 
the basis of their sequence similarity. Figure 14 shows the sequences of predicted 
SRY boxes from 8 primates (Whitfield et al., 1993). Dots indicate agreement with the 
HMG box of Human SRY. All the residues modified during evolution map to a 
different position from those associated with sex reversal phenotypes in humans. 
To study the behavior of the DNA protein complexes of SRYs boxes it was first 
necessary to express and purify the corresponding proteins. We obtained DNA 
fragments coding for SRY boxes by PCR of total genomic DNA with the same 
specific oligonucleotides used for sex reversal mutations. We amplified DNA coding 
for SRY proteins from genomic DNA of common chimpanzee (Pan troglodytes), 
pygmy chimpanzee (Pan paniscus), orang-utan (Pongo pygmaeus), gorilla (Gorilla 
gorilla), gibbon (Hylobates lar), baboon (Papio spp. ) and marmoset (Callithrix jaccus). 
Briefly, to allow the synthesis of the boxes in E. coli, the first amino acids (aa) of the 
HMG box (N in marmoset, D for all the other boxes listed in figure 14) was changed 
to M to provide a translation start codon, and the last (N for chimpanzee, pygmy 
chimpanzee and marmoset, K for all the other boxes in figure 14) was changed to a 
stop codon. The same oligos, SRY box dir and SRY box rev, used for the 
amplification of human sex reversal SRYs were used for PCR according to conditions 
already reported in the previous section. Reaction products were cleaved with NdeI 
and Hindlll, gel purified and cloned between Mel and HindlII sites of plasmid pT7- 
7. The resulting plasmids were introduced in strain B121 (DE3), as described in the 
section concerning the construction of human SRY mutant proteins. The 
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Fig. 14. Alignment of HMG-box sequences from SRY proteins of primates. Dots 
indicate agreement with the human as sequence. Upper case letters indicate non- 
synonymous mutations with the resultant as change shown. The gorilla and human 
SRY boxes are exactly identical in sequence. The last line reports some single-site 
substitutions in humans that cause sex reversal: the mutated as is indicated. 
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corresponding peptides, which are called SRY boxes, were produced efficiently as 
described in the previous section, and were soluble. Recombinant proteins were 
purified in the same way as described in the first section of this work. Briefly, nucleic 
acids were removed by batch absorption to DEAE-cellulose at 0.45 M NaCl; the 
supernatant was filtered and applied to a Mono S HR5/5 FPLC column (Pharmacia) 
equilibrated with 20 mM HEPES pH 7.9,0.2 mM EDTA. The column was eluted 
with a linear gradient from 0M to 2M NaCI in 20 mM HEPES pH 7.9,0.2 mm 
EDTA. SRY boxes were eluted in fractions containing about IM NaCI and were 
more than 99% pure. Protein concentrations were estimated by reading at 280 nm and 
by scanning protein titrations on SDS-polyacrylamide gels. 
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2.8 ARCHITECTURE OF THE DNA COMPLEXES INDUCED BY PRIMATE 
SRY PROTEINS 
To estimate the dissociation constant of the complexes between SRY boxes and 
DNA, and the deformation induced in DNA, we performed bandshift and circular 
permutation assays. 
The same short sequence, AACAAAG, cloned between directly repeated sequences in 
plasmid pBend2 shown in the previous section to be a good DNA binding site for wt 
human and mutant SRY proteins was used as a probe for bandshift and circular 
permutation assays. Experimental conditions are the same as reported with human 
SRY proteins. 
Cleavage with several restriction endonucleases yielded the same set of fragments of 
identical length and circularly permuted sequence (figure 15). Fragments D and A 
were used to estimate the affinity of the various primates SRY boxes for the 
AACAAAG binding site. Individual SRY boxes were titrated on limiting amounts of 
DNA in a band shift assay: as described in the first section, under conditions of 
protein excess, the KD corresponds to the concentration of SRY boxes where half of 
the input DNA is engaged in the specific complex. All SRY boxes had identical 
titration profiles (not shown). Figure 15 shows a bandshift assay performed using 
labelled DNA fragment D, which contains the AACAAAG binding site in the middle, 
with the same amount of pure SRY boxes from different primates. The amount of free 
and complexed DNA is very similar in all cases, and corresponds to a dissociation 
constant of 10-8 M. The different electrophoretic mobility of DNA-protein complexes 
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Fig. l5. DNA binding and bending properties of HMG-boxes of primate SRY proteins. 
(A) Construction of the probes for the electrophoretic mobility shift and circular 
permutation assays. Plasmid pBend2CD3e, containing the 5'-AACAAAG binding site 
(hatched box) flanked by tandemly duplicated DNA sequences, was cleaved at the 
restriction sites indicated in the map. The DNA fragments obtained in this way 
(designated A-G) contain circular permutations of the same sequence of 141 bp. (B) 
The different SRY-boxes have the same affinity for the 5'-AACAAAG binding site. 
SRY-box peptides (5 nu) of primates (BA, baboon, CH, chimpanzee. GO, gorilla. Gl. 
gibbon. OR, orang, MA, marmoset, PY, pygmy chimpanzee) were mixed with 
labelled DNA fragment D (S fmol) in 9 ul of DNA binding butter (S°'o Ficoll. 100 mil 
NaCl, 10 mVl HEPES pH 79). After incubation for 10 min on ice, 5 u1 samples were 
subjected to electrophoresis at IIV cm- I at room temperature in vertical 10° o P-A 
gels containing 45 mil Tris-borate buffer. pH 8.3 The gels were dried and 
autoradiographed with Kodak XAR-5 films at -SOC for 24-72 h. Under conditions of 
protein excess, these concentrations of SRY-boxes (IU-Sivl) cause the shift of half of 
the input DNA. and correspond to the dissociation constant of the complex. 
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We then tested the elecrophoretic mobility of the different SRY boxes with the 
complete set of labelled DNA fragments with circular permuted sequence. As 
described in more detail in the previous section, DNA fragments with a distortion in 
the middle of the molecule have a different shape, and hence a different 
electrophoretic mobility, compared with DNA fragments of identical length and 
composition with a distortion near one end; their rate of migration in polyacrylamide 
gels allows the estimations of the amount of distortion introduced in DNA. All SRY 
boxes were analysed; figure 16 shows a typical result obtained with the pygmy chimp. 
and marmoset SRY boxes. The bending centre always maps to the 5' AACAAAG 
binding site. Protein complexes with fragment A and G had identical mobility for all 
SRY boxes, while the mobility of the complex with fragment D was slightly variable. 
Moreover, the variation is small indeed, and the deduced DNA angles are very similar 
in the complex formed by all primate SRY boxes (Table 4). The small differences in 
the angles induced by SRY boxes of different primates does not correlate with the 
divergence times of the different species from the primate evolutionary tree. In fact 
the difference in the induced bend between human and chimpanzee is slightly more 
than between human and gibbon or between human and marmoset, contrary to the 
evolutionary divergence times: (chimp vs. human 7 millions of years (Myr), gibbon vs. 
human 19 Myr, marmoset vs. human 27 Myr. Nei, 1987). These data suggest that the 
differences are not significant, and that essentially the same geometry of the SRY- 
DNA complex is required for sex determination. Thus, the DNA binding and bending 
properties of the marmoset SRY box are not significantly different from those of the 
human SRY box, although it differs in 4 aas. Therefore, the alternative as in the SRY 
boxes of the different primates must be considered neutral mutations. This has to be 
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Fib. 16. Circular permutation analysis of the DNA flexure induced SRY-boxes of 
marmoset and pygmy chimpanzee. Eight fmol of circular permuted DNA fragments 
(from A to G) were mixed with 5 ng of SRY boxes (first panel, marmoset, second, 
pygmy chimpanzee). After incubation on ice, the samples were assayed as described in 
material and methods. The difference in amplitude of the two curves corresponds to 

































Table 4. No correlation between the time of divergence from the human line of 
descent and the amplitude of the deflection in DNA induced by SRY. 
Time of divergence from human (expressed in Myr) as reported by Nei (1987). 
However, the exact times are subject to some controversy and it is still undecided 
for baboon (*). 
DitTerence of deflection means the difference of angles induced in DNA by SRYs of 
monkeys compared to the human one. ( angle of monkey minus angle of human). 
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protein (sex reversal) in humans. In fact, as shown before, mutations M641,190M, 
G95R, K106I in human SRY reduce the DNA binding affinity to the AACAAAG site; 




3.1 HOW DOES SRY WORK? 
The product of the sex-determining SRY gene is a DNA binding protein that controls 
the differentiation of pre-Sertoli cells during embryonic life. The only conserved part 
of the SRY protein in related animals is the DNA binding domain, which recognises a 
defined repertoire of sites. However, the sequence selectivity of SRY is rather low 
and indistinguishable from that of other proteins with similar DNA-binding domains 
but very different biological functions. Both we and others have shown that SRY 
induces a large alteration of the local geometry of DNA sites it binds to, and that 
indeed DNA molecules that already contain sharp bends or kinks are actually bound 
by SRY with high affinity and selectivity, irrespective of the sequences that they 
contain (Ferrari et al., 1992; Giese et al., 1992). Such unusual properties suggest that 
the DNA bending function might be central to the biological activity of SRY, as well 
as of other protein with similar HMG box DNA binding domains (Grosschedl et al., 
1994; Bianchi, 1994). As illustrated in Figure 17, SRY would promote the interaction 
of flanking transcription factors by acting mechanically on the DNA molecule. Two 
predictions are central to the model: SRY does not promote transcription on its own, 
but depends on the presence of "left" and "right" transcription factors, which are only 
active if physically associated. In fact, known SRYs lack recognisable transcription 
activation domains, and their sequences are completely divergent outside the HMG 
box. In contrast, the existence of the predicted "left" and "right" factors rests on the 
analogy with the LEF-1/TCRa system (Giese et al., 1992; Ho and Leiden 1990; Giese 
and Grosschedl, 1993). 
The left and right transcription factors would interact only in the presence of SRY, 
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Fig. 17. A model for the action of SRY protein. The human testis-determining factor 
SRY is a DNA binding protein belonging to the HMG box class. SRY is most related 
to a number of gene-specific transcriptional regulators, which recognise specific 
sequences in DNA. However, the recognition takes place mainly through the minor 
groove and has a low selectivity. In addition, SRY proteins even from closely related 
mammals share similarity only within the IIG box DNA binding domain, and 
diverge considerably outside of it. This argues against the presence of additional 
domains involved in transcriptional transactivation. However, SRY bends the DNA 
considerably after binding to some sites, and this may promote protein-protein 
interactions between factors (L for "left"' and R for "right") bound to either side of the 
SRY binding site. Thus, a mechanical action on DNA may induce the formation of a 
nucleoprotein complex endowed with high specificity (requiring at least three different 
sites bound by different proteins), high stability (the protein-protein and protein-DNA 
interactions would he cooperative and reinforce each other) and biological activity 
(through domains present on the L and R proteins). The experiments reported in this 
paper support the notion that the deformation induced by SRY must be geometrically 
precise to serve as a genetic switch. 
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nucleoprotein complex in a specifically defined way, which can neither be attained 
spontaneously nor by proteins that can bind the same sites as SRY. 
The data we report test the prediction that the geometry of the SRY/DNA complex 
must be a prime determinant in sex determination. A mutation that alters the geometry 
of the nucleoprotein complex is associated with a loss of function of SRY. Moreover, 
different binding sites can be discriminated on the basis of the geometry they adopt 
when bound by SRY. 
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3.2 DISSECTION OF THE DNA BINDING AND DNA BENDING 
ACTIVITIES OF SRY PROTEIN 
The most obvious result of our analysis is that the DNA binding and DNA bending 
activities of SRY protein can be separated. The K1061 amino acid substitution in SRY 
reduces the DNA binding affinity of the protein more than 100-fold, and yet still 
allows the bending of the DNA target to the same extent attained by the wild type 
protein. Conversely, the M641 amino acid substitution reduces the DNA binding 
affinity only 3-fold, but causes a reduction in DNA bending from about 750 to about 
56°. 
The non-correlation between the binding affinity of the SRY variants and the extent of 
deformation caused in DNA is at first sight surprising. How can a weakly binding 
protein like SRY K106I cause a large deformation in DNA? The simple answer is that 
mutant K106I binds weakly precisely because it still deforms DNA significantly. The 
binding affinity of a protein to its ligand is related to the difference in free energy at 
equilibrium between the bound and unbound states of the system that comprises the 
protein, the ligand and the aqueous environment. The free energy variation between 
the bound and unbound states of the SRY/DNA system can be decomposed 
(somewhat arbitrarily) in several contributions, as shown in the diagram in figure 18. 
One contribution corresponds to the establishment of chemical hydrogen bonds 
between SRY and the nucleic acid, irrespective of the sequence or the conformation 
of the DNA, in a non-specific mode. A second contribution corresponds to the 
formation of sequence-specific contacts between SRY and a favored binding site. The 







Fig. 18 Thermodynamics of the binding of SRY boxes to DNA. The chemical 
potential of SRY protein and of a linear DNA molecule containing a preferred target 
site are indicated as µOP and µOD, respectively; the chemical potential of the complex 
as µODP. The difference in the energy levels µOP+gOD and gODP represents the 
kGO' variation in free energy associated with complex formation. The total free 
energy variation can be divided in several contributions: A, the free energy variation 
associated with non-specitic protein-DNA interactions; B, that associated with 
sequence-specific interactions; C, the one associated with the deformation of the 
DNA; D, the one associated with conformation-specific interactions. The formation of 
the complex is thermodynamically favored so long as A+B+D is larger in absolute 
value than C. 
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up energy. A last contribution represents shape-specific interactions between the 
protein and the DNA, once this is deformed. 
If the mutant K106I deforms the DNA in the same way as the wild type, the negative 
contribution will be the same. Then, if the mutation reduces any one of the other 
contributions, the sum of the free energy variations of all the contributions will be 
close to zero, and the protein will bind weakly to its ligand. 
A second key result of our analysis is that the affinity of the various mutated SRY box 
domains for specific sites on linear DNA is variable, but the affinity for the four-way 
junction DNA is identical. This implies that the mechanistic details of duplex binding 
and junction binding are different, at least partially. We suggest that the SRY 
mutations we have analysed do not affect the shape-recognising properties of the 
HMG box, but one of the steps by which the linear DNA molecule is moulded into a 
specific shape. On the biological level, the equal recognition of four-way junctions by 
wild type and mutant SRY proteins formally rules out distorted structures as the 
physiological target of SRY, and suggests that sequence recognition is essential 
although probably not sufficient for the action of SRY in differentiation. The model in 
Figure 19 summarises our current thinking on SRY binding to DNA. We suggest that 
the DNA binding domain of SRY contains sites that allow sequence discrimination in 
linear DNA, sites that deflect the DNA, and sites that establish conformation-specific 
contacts with bent DNA. The correspondence between sites and specific amino acid 
residues need not be unequivocal: each site will made up of several residues forming a 
surface, and a certain residue might contribute to more than one site at the same time. 
All three sites must be involved in the establishment of protein-DNA contacts in 
complexes containing the SRY box and the distorted double helix, and mutations 








Fig. 19. A schematic model for the interaction of SRY proteins with linear and four- 
way junction DNAs. The DNA-binding domain of wild type SRY is depicted here as a 
rounded object with three sites which are important for the interaction with DNA: the 
grey disc is involved in sequence-specific recognition, the zig-zag is associated with 
conformation-specific interactions, and the square with bars represents the site in the 
protein responsible for the deflection of linear DNA. In reality, each site may be 
composed of multiple residues, conversely, some residues may contribute to more 
than one of the sites that are shown here as independent. (A) Interaction with linear 
DNA. When wild type SRY interacts with a specific sequence in linear DNA (1), all 
three sites will establish contacts with the DNA in the complex, and the DNA 
deflection will be mainly determined by the burrowing of the site represented as the 
square with bars into the minor groove. The substitution of a residue in this site 
(chequered disc) will modify marginally the overall affinity of the protein for the 
DNA, but will have a profound effect on the overall geometry of the complex (2) (B) 
Interaction with four-way junctions. The affinity of SRY for four-way junctions does 
not depend on the sequence of the DNA. Moreover, the DNA already contains kinks. 
Therefore, we expect that the sequence-specific site and the DNA-deflecting site will 
not play important roles in this type of interaction, which will be mainly governed by 
the conformation-specific site. To stress this point, in the drawing the grey disc and 
the square with bars are drawn as not making contacts with the four-wayy junction, 
although of course this may not reflect the real situation. 
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specific target sequence in linear DNA. However, only amino acid substitutions in the 
DNA deflecting site will modify the geometry of the nucleoprotein complex. Thus, 
M64 must be one of the residues involved in DNA distortion. The interaction with 
four-way junctions must mimic at least partly the interaction with double-stranded 
DNA, and probably involves the same conformation-specific contacts. The site for 
sequence-specific recognition cannot contribute much to the interaction with four-way 
junctions, since this is largely sequence-insensitive (Ferrari et al., 1992). Likewise, the 
site responsible for DNA distortion might not play an important role in the interaction 
with the four-way junction, which is already distorted and is predicted to have a 
widened minor groove (Lilley and Clegg, 1993). The fact that none of the amino acid 
substitutions we examined altered the affinity of SRY for four-way junctions indicates 
that none of the affected residues belong to the conformation-specific site. 
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3.3 THE CONTRIBUTION OF THE DNA SEQUENCE TO THE 
ORGANISATION OF SRY-INDUCED NUCLEOPROTEIN COMPLEXES. 
As discussed in the previous paragraph, the biological activity of SRY appears to 
depend critically on the recognition of specific sequences. We have shown that target 
sites with altered sequences can still be recognised by SRY, but will be bent 
differently. This offers a solution to the puzzle of the limited sequence-specificity of 
SRY, as opposed to the required sequence-specificity of its action. A certain DNA 
sequence may turn out to be a key element in the regulation of gene expression not 
because SRY binds especially well to it, but because the SRY-induced angle is the 
correct one for the establishment of a productive complex involving other proteins 
(see figure 17). In fact, different HMG box proteins may recognise the same 
sequence, but they will produce different angles: while human SRY induces an angle 
of about 800, LEF-1 produces an angle of about 1300 (Giese et al., 1992). 
At a mechanistic level, the intrinsic bendability of specific sequences may ultimately 
dictate whether SRY will bind to them or not, as suggested by King and Weiss 
(1993), and how much the DNA will be bent in the complex. Studies on the 
adaptation of double-helical DNA to the curved path around nucleosomes have 
indicated that different sequences have indeed different flexibility (reviewed by 
Travers, 1988). In any event, it is clear that the issue of bendability and the issue of 
angle-choice taken together, amount to the likely existence of yet another 
informational level in DNA readout: one that ultimately depends on the sequence, but 
in quite indirect and complex ways. 
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3.4 CORRELATION BETWEEN THE DNA BINDING PROPERTIES OF 
THE SRY BOX MUTANTS AND THE PHENOTYPE OF THE AFFECTED 
PATIENTS 
In this study, we have adopted the classical genetic approach of understanding a 
phenomenon by considering mutations that perturb it. To what extent, however, is 
there a causal relationship between the chemical-physical properties of the DNA 
binding domains of mutant SRY proteins and the lack of testes formation? A DNA- 
binding protein must bind to DNA if it is to work, and in this respect the biological 
consequences of mutations G95R and K106I correspond well to the reduced binding 
affinity of the corresponding protein, as had already been noted in a previous study 
(Harley et al., 1992). At the other extreme, mutations F109S and 190M can be 
transmitted from father to son and are-indeed present in a number of physiologically 
differentiated males: they clearly behave as conditional mutations. From this point of 
view, it is quite logical that the mutated proteins differ little from wild type SRY with 
respect to their DNA binding and DNA bending properties. Their failure to function in 
some cases, but not all, must depend on the genetic background or the environment. It 
has already been shown that the genetic background is important in sex determination: 
in the mouse when the variant poschiavinus Y chromosome is present on a C57BL6 
background, XY females result, but the same chromosome gives males in all other 
backgrounds. 
Mutant M641 is at the same time more informative, and more difficult to interpret. 
This mutation is de novo, which suggests that it is always associated with sex- 
reversal. The 3-fold reduction in DNA binding affinity with respect to the wild type is 
unimpressive, and it is unlikely that a reduction of this extent would completely 
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subvert its function. On the other hand, a reduction in the deformation of the DNA 
translates into a significant dislocation of proteins bound a few helical turns from the 
SRY binding site. We cannot measure the exact difference in the architecture of the 
SRY-DNA complex responsible for sex determination for two reasons: circular 
permutation is a low-resolution assay and no bona fide target site for SRY has been 
identified. The first limitation is not very relevant, since in any event the differences in 
DNA distortion are large enough to be identified qualitatively. The second limitation 
is more critical, but it is clear that M641 always distorts the DNA differently from the 
wild type protein, whatever the sequence of the target site. 
There is another limit in our understanding of the role of DNA distortion in SRY 
action: we do not know how tolerant to perturbations is the system. To obtain a 
rough idea of the degree of wobble allowed in SRY-induced nucleoprotein 
complexes, we compared the deflection angles induced by human SRY and its primate 
and mouse counterparts. Primate SRY proteins (gorilla, gibbon, baboon, chimpanzee, 
pygmy chimpanzee, orang-utan, and marmoset) all bend the AACAAAG site in the 
CD3e enhancer in a very similar way to human SRY (the maximum difference is 6 
degrees), despite the accumulation of several amino acid substitutions in the DNA 
binding domain. Such evolutionary conservation suggests a very limited permissible 
wobble. On the other hand, the angle produced by mouse SRY appears to be quite 
different from that produced by human SRY (Giese et al., 1994), and this correlates 
with the inability of transgenic human SRY to cause male differentiation in mice 
(Koopman et al., 1991). The angle variation may be the key molecular defect of 
mutant M64I, although this deduction is not supported by direct experiments on 
transcriptional control. However, we have excluded the possibility that the M64I SRY 
mutant causes gonadal dysgenesis because its sequence specificity is different from 
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that of the wild type protein: both proteins select a comparable repertoire of binding 
sequences in selection/amplification experiments. 
In conclusion, we have shown that the DNA binding and DNA bending activities of 
SRY protein can be dissociated by mutation. The DNA bending activity of SRY is 
also strongly affected by the underlying sequence of the binding site. We have also 
shown that the defect of one mutant SRY protein might be traced to its anomalous 
DNA bending activity. Our findings are in keeping with the hypothesis of a direct role 
of protein-induced DNA bending in certain types of transcriptional control and should 
stimulate increased efforts in the study of DNA structural plasticity and in the search 
of proteins that modulate such plasticity. 
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3.5 MOLECULAR BASIS OF HUMAN 46X, Y SEX REVERSAL REVEALED 
FROM THE THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE 
HUMAN SRY-DNA COMPLEX 
While this work was in progress, the solution structure of the specific complex 
between the human SRY box and its hypothetical DNA target site was determined by 
multidimensional NMR spectroscopy. The SRY box has a twisted L shape that 
presents a concave surface (made up of three helices and the N- and C- terminal 
strands) to the DNA for sequence-specific recognition (Werner et al., 1995). Binding 
of SRY to its DNA target site occurs exclusively in the minor groove and induces a 
large conformational change in the DNA. The DNA in the complex has an overall 700- 
800 bend and is helically unwound relative to classical A and B DNA (figure 18). 
The structure of the complex reveals the effects of point mutations that cause sex 
reversal phenotype at the atomic level. 
From the genetic stand point, naturally occurring point mutations in hSRY are of two 
types: inherited mutations with variable penetrance and de novo mutations with full 
penetrance (see introduction and table 1). 
Clearly, the functional effects of the former must be considerably less severe than 
those of the latter. From a structural point of view, the point mutations also fall into 
two categories: those that affect the packing of residues within the protein core and 
those that involve residues that directly contact the DNA. 
Two inherited point mutation, 190M (I 35 in Figure 21) 'and F109S (F 54 in Figure 
21) result in packing defects that would be expected to destabilise the protein, but 
they are not so crucial for the correct packing as V60 (V5 in Figure 21) that serves to 
position K 73 and Y 74 for interaction with the DNA. 
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Fib. 20 The interaction of hSRYbox with DNA (from Werner et al. ) 
Three views (A-C) are displayed. The protein is shown as a schematic ribbon drawing 
in green, and the colour coding used for the DNA bases is red for A. lilac for T, dark 
blue for G and light blue for C. Side chains that contact the DNA bases are depicted 
in yellow in (C) (D) shows the same view as in (C) with the molecular surface of the 
protein shown in grey and the DNA atoms in yellow The patches of blue on the 
protein surface indicate the location of the side chains of tour of the seven residues 
that interact with the DNA bases. 
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F 109 (F 54 of Figure 21) is a buried residue within the hydrophobic core that packs 
against A 11, V 14, W 15 and F 55 as shown in the model reported in the Figure 21. 
Substitution by the polar S at this position would be anticipated to destabilise the 
protein, but this effect, however, may not be sufficient to perturb the DNA binding 
properties of the F109S mutant, but may accelerate its degradation within the cell. 
The other packing defect point mutant, K106I (K 51 in Figure 21), plays a role in the 
interaction with the DNA binding core and the rest of the protein. The aliphatic 
portion of the side chain of K51 in Figure 21 is packed between L 46 and F 55. 
Introduction of a branched Ile side chain with two bulky methyl groups at this 
position may disrupt F 55 from the hydrophobic core and partially displace L 46, 
destabilising the packing of helices 2 and 3. 
The remaining de novo point mutations involve residues that contact the DNA. The 
G95R (Arg 7 in Figure 22) mutant removes hydrophobic contacts with the sugar of 
C4 and a salt bridge to the phosphate of A5. Owing to shortening of the side chain, 
the M641 (Met 9 Ile of Figure 22) mutant will disrupt extensive van der Waals 
contacts with the deoxyribose of A5 and A6 and with the 03 atom of A6 that is 
located at the hinge point of the bend between base pair 5 and 6 (Figure 22). 
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Fig. 21. Ribbon drawing of hSRYbox. 
The backbone ribbon is shown in green, and side chains with less than 20% and 
between 20% and 50% of their surface (relative to an extended Gly-X-Gly tripeptide 








ý_ Phe12 I1e13 
_ T12 // ý% ýý 
A1a24 
Fig. 2 Summary of the contacts between hSRYbox and DNA. 
the DNA is represented as a cylindrical projection viewed in the minor groove with 
the bases depicted as thick black lines, the deoxyribose sugar rings as pentagons, and 
the phosphate as stippled circles. 
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MATERIALS AND METHODS 
4.1 ALKALINE LYSIS MINIPREP 
The alkaline lysis procedure is the most commonly used miniprep method. Plasmid 
DNA is prepared from small amounts of many different cultures (1 to 24) of plasmid- 
containing bacteria. Bacteria are lysed by treatment with a solution containing sodium 
dodecyl sulfate (SDS) and NaOH (SDS denatures bacterial proteins, and NaOH 
denatures chromosomal and plasmid DNA). The mixture is neutralized with potassium 
acetate, causing the covalently closed plasmid DNA to reanneal rapidly. Most of the 
chromosomal DNA and bacterial proteins precipitate--as does the SDS, which forms a 
complex with potassium--and are removed by centrifugation. The reannealed plasmid 
DNA from the supernatant is then concentrated by ethanol precipitation. 
Materials 
LB medium containing appropriate antibiotic. 
Glucose/Tris/EDTA (GTE) solution 
TE buffer. 
NaOH/SDS solution 
Potassium acetate solution 
95% and 70% ethanol 
10 mg/ml DNase-free RNase. 
1.5-m1 disposable microcentrifuge tubes 
Methods 
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1. Inoculate 5 ml sterile LB medium with a single bacterial colony. Grow to saturation 
(overnight). 
2. Spin 1.5 ml of cells 20 sec in a microcentrifuge at maximum speed to pellet. 
Remove the supernatant with a Pasteur pipet. 
The spins in steps 2 and 6 can be performed at 4C or at room temperature. Longer 
spins make it difficult to resuspend cells. 
3. Resuspend pellet in 100 ul GTE solution and let sit 5 min at room temperature. 
Be sure cells are completely resuspended. 
4. Add 200 ul NaOH/SDS solution, mix by tapping tube with finger, and place on ice 
for 5 min. 
5. Add 150 ul potassium acetate solution and vortex at maximum speed for 2 sec to 
mix. Place on ice for 5 min. 
Be sure mixing is complete. 
6. Spin 3 min as in step 2 to pellet cell debris and chromosomal DNA. 
7. Transfer supernatant to a fresh tube, mix it with 0.8 ml of 95% ethanol, and let sit 2 
min at room temperature to precipitate nucleic acids. 
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8. Spin 1 min at room temperature to pellet plasmid DNA and RNA. 
9. Remove supernatant, wash the pellet with 1 ml of 70% ethanol, and dry pellet 
under vacuum. 
10. Resuspend the pellet in 30 ul TE buffer and store as in support protocol. Use 2.5 
to 5 ul of the resuspended DNA for a restriction digestion. 
4.2 PREPARATION OF CRUDE LYSATE BY ALKALINE LYSIS: MAXI 
PREP 
Materials 
LB medium or enriched medium (e. g., superbroth or terrific broth) containing 
ampicillin or other appropriate selective agent . 
Plasmid-bearing E. coli strain. 
Glucose/Tris/EDTA solution. 
25 mg/ml hen egg white lysozyme in glucose/Tris/EDTA solution (prepare fresh). 
0.2 M NaOH/1% (w/v) SDS [prepare fresh from 10 M NaOH and 10% (w/v) SDS 
stocks] 
3M potassium acetate solution, pH -5.5 
Isopropanol 
70% ethanol 
Sorvall GSA, GS-3, or Beckman JA-10 rotor or equivalent 
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High-speed centrifuge tubes with >=20-ml capacity (e. g., Oak Ridge centrifuge tubes) 
Sorvall SS-34 or Beckman JA-17 rotor or equivalent 
Methods 
1. Inoculate 5 ml LB medium or enriched medium containing selective agent (most 
commonly ampicillin) with a single colony of E. coli containing the desired plasmid. 
Grow at 37C with vigorous shaking overnight. 
2. Inoculate 500 ml LB medium or enriched medium containing selective agent in a 2- 
liter flask with -1 ml of overnight culture. Grow at 37C until culture is saturated 
(OD600 4). 
To increase yields, maximize aeration using a flask with high surface area (whose 
volume exceeds the culture volume--i. e., is >2 liters) and baffles and shake at >400 
rpm. Alternatively, treat cultures of cells growing logarithmically with 
chloramphenicol to amplify the plasmids . 
Growing the bacteria in medium that 
supports higher cell densities also increases the yield. These media include M9, terrific 
broth, and LB medium containing 0.1% (w/v) glucose These media can increase 
plasmid yields 2- to 10-fold; different plasmids respond to the media differently. Most 
plasmids commonly used today, particularly derivatives of the pUC series, grow at a 
copy number high enough to routinely yield 1 to 5 mg plasmid DNA from a 500-m1 
culture grown in LB medium. 
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An important consideration when using enriched medium is the method to be used for 
final purification of plasmid DNA. Increased yield poses no problems when using 
CsCVethidium bromide or PEG purification. However, the capacity of some 
commercially available chromatography columns--e. g., the Qiagen-tip 2500 (Qiagen) 
and Wizard Maxiprep (Promega)--is easily exceeded. Therefore, the increased yield of 
plasmid DNA in the crude lysate will not result in increased recovery from the 
column. The pZ523 column (5 Prime->3 Prime) does not require that plasmid DNA 
bind to the column and can be used to purify larger amounts of DNA. 
3. Collect cells by centrifuging 10 min at 6000 xg (-6000 rpm in Sorvall GSA/GS-3 
or Beckman JA-10 rotors), 4C. 
If necessary the pellets can be stored frozen indefinitely at -20 or -70C. 
4. Resuspend pellet from 500-ml culture in 4 ml glucose/Tris/EDTA solution and 
transfer to high-speed centrifuge tube with >=20-nil capacity. 
Lyse the cells 
S. Add 1 ml of 25 mg/ml hen egg white lysozyme in glucose/Tris/EDTA solution. 
Resuspend the pellet completely in this solution and allow it to stand 10 min at room 
temperature. 
Neither glucose nor lysozyme is absolutely necessary for the success of the procedure. 
Glucose serves as a buffer in step 6 when the pH of the solution is greatly increased 
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by addition of NaOH. Glucose provides buffering in the range of pH 12 and, by 
preventing the pH from rising too drastically in step 6, increases the efficiency of 
precipitation in step 7 (when the pH is lowered by addition of potassium acetate). 
Lysozyme assists in the destruction of bacterial cell walls and subsequent release of 
plasmid DNA. Bacterial debris and soluble proteins are precipitated in step 7. One 
problem that can reduce recovery of plasmid DNA is inefficient separation of plasmid 
DNA from cellular debris. Lysozyme helps increase yield by reducing the amount of 
plasmid DNA trapped in partially degraded cell material and subsequently lost by 
precipitation at step 7. 
The effort and expense required to include glucose and lysozyme in step 5 is 
negligible. The efficiency gained in streamlining the procedure by omitting them is 
also negligible. However, the potential for loss of plasmid DNA when these 
components are not included is measurable and worth avoiding. It should be noted 
that some commercially available chromatographic systems (e. g., Qiagen) rely on 
inefficient bacterial lysis to reduce contamination of plasmid DNA with chromosomal 
DNA. Although omitting lysozyme reduces the recovery of plasmid DNA, when using 
these products the manufacturer's recommendations should be followed. 
When chromatographic methods are used for final purification of plasmid DNA, it is 
essential to degrade RNA that contaminates the lysate, and will copurify with plasmid 
DNA. Treating the lysate with RNase A is the most efficient and economical method 
for degrading RNA. This can be accomplished at any step in the preparation of crude 
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lysate, it is most convenient to do it at step 5, by adding RNase A to the 
glucose/Tris/EDTA solution to a final concentration of 50 ug/ml. 
6. Add 10 ml freshly prepared 0.2 M NaOH/1% SDS and mix by stirring gently with a 
pipet until solution becomes homogeneous and clears. Let stand 10 min on ice. 
The solution should become very viscous. 
7. Add 7.5 ml of 3M potassium acetate solution and again stir gently with a pipet 
until viscosity is reduced and a large precipitate forms. Let stand 10 min on ice. 
8. Centrifuge 10 min at 20,000 xg (13,000 rpm in Sorvall SS-34; 12,500 rpm in 
Beckman JA- 17), 4C. 
A large, fairly compact pellet will form; this contains most of the chromosomal DNA, 
SDS-protein complexes, and other cellular debris. Plasmid DNA remains in the 
translucent supernatant. 
Addition of -0.5 ml chloroform before the centrifugation can help reduce floating 
material. 
Precipitate plasmid DNA 
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9. Decant the supernatant into a clean centrifuge tube. Pour it through several layers 
of cheesecloth if any floating material is visible. Add 0.6 vol isopropanol, mix by 
inversion, and let stand 5 to 10 min at room temperature. 
If the supernatant is cloudy or contains floating material, repeat centrifugation (step 8) 
before adding isopropanol. 
10. Recover nucleic acids by centrifuging 10 min at 15,000 xg (11,500 rpm in SS-34 
rotor; 10,500 rpm in JA-17 rotor), room temperature. 
11. Wash the pellet with 2 ml of 70% ethanol; centrifuge briefly at 15,000 x g, room 
temperature, to collect pellet. Aspirate ethanol and dry pellet under vacuum. 
The pellet can be stored indefinitely at 4C. 
Materials 
Potassium acetate solution (3 M), pH -5.5 
294 g potassium acetate (3 M final) 
50 ml 90% formic acid (1.18 M final) 
H2O to I liter 
Store indefinitely at room temperature 
Sucrose/Tris/EDTA solution 
25% (w/v) sucrose 
50 mM Tris-Cl, pH 8.0 
100 mM EDTA, pH 8.0 
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Store indefinitely at 4C 
4.3 TRANSFORMATION USING CALCIUM CHLORIDE 
Escherichia coli cells are grown to log phase. Cells are concentrated by centrifugation 
and resuspended in a solution containing calcium chloride. Exposure to calcium ions 
renders the cells able to take up DNA, or competent. Plasmid DNA is mixed with the 
cells and presumably adheres to them. The mixture of DNA and cells is then heat 
shocked, which allows the DNA to efficiently enter the cells. The cells are grown in 
nonselective medium to allow synthesis of plasmid-encoded antibiotic resistance 
proteins, then plated on antibiotic-containing medium to allow identification of 
plasmid-containing colonies. 
Materials 
Single colony of E. coli cells 
LB medium 
CaCl2 solution, ice-cold 
LB plates containing ampicillin 
Plasmid DNA (pBend 2, pT7 hSRY box... ) 
Chilled 50-m1 polypropylene tubes 
Beckman JS-5.2 rotor or equivalent 
42C water bath 
All materials and reagents coming into contact with bacteria must be sterile. 
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4.4 PREPARE COMPETENT CELLS 
Method 
1. Inoculate a single colony of E. coli (DH5, B121 (DE3)) cells into 50 ml LB 
medium. Grow overnight at 37C with moderate shaking (250 rpm) 
Alternatively, grow a 5-ml culture overnight in a test tube on a roller drum. 
2. Inoculate 4 ml of the culture into 400 ml LB medium in a sterile 2-liter flask. Grow 
at 37C, shaking (250 rpm), to an OD59o of 0.375. 
This procedure requires that cells be growing rapidly (early- or mid-log phase). 
Accordingly, it is very important that the growing cells have sufficient air. A 1-liter 
baffle flask can be used instead of the 2-liter flask. Overgrowth of culture (beyond 
OD59o of 0.4) decreases the efficiency of transformation. 
3. Aliquot culture into eight 50-m1 prechilled, sterile polypropylene tubes and leave 
the tubes on ice 5 to 10 min. 
Cells should be kept cold for all subsequent steps. 
Larger tubes or bottles can be used to centrifuge cells if volumes of all subsequent 
solutions are increased in direct proportion. 
4. Centrifuge cells 7 min at 3000 rpm (1600 x g), 4C. Allow centrifuge to decelerate 
without brake. 
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We have not attempted to determine whether deceleration without braking is critical 
to this procedure. However, we do not use the brake for this step or for the 
subsequent centrifugation steps. 
5. Pour off supernatant and resuspend each pellet in 10 ml ice-cold CaCl2 solution. 
Resuspension should be performed very gently and all cells kept on ice. 
6. Centrifuge cells 5 min at 2500 rpm (1100 x g), 4C. Discard supernatant and 
resuspend each pellet in 10 ml cold CaCl2 solution. Keep resuspended cells on ice for 
30 min. 
7. Centrifuge cells 5 min at 2500 rpm (1100 x g), 4C. Discard supernatant and 
resuspend each pellet in 2 ml of ice-cold CaCl2 solution. 
It is important to resuspend this final pellet well. The suspension may be left on ice for 
several days. For many strains (e. g., DH5) competency increases with increasing time 
on ice, and reaches a maximum at 12 to 24 hr. This is not true for B121 (DE3) cells, 
which should be frozen immediately. 
8. Dispense cells into prechilled, sterile polypropylene tubes (250-u1 aliquots are 
convenient). Freeze immediately at -70C. 
Assess competency of cells 
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9. Use 10 ng of pBR322 to transform 100 ul of competent cells according to the steps 
provided below. Plate appropriate aliquots (1,10, and 25 ul) of the transformation 
culture on LB/ampicillin plates and incubate at 37C overnight. 
10. The number of transformant colonies per aliquot volume (ul) x 105 is equal to the 
number of transformants per microgram of DNA. 
Transformation efficiencies of 107-108 and 106-107 are obtained for E. coli MC 1061 
and DHS, respectively. Competency of strains decreases very slowly over months of 
storage time. 
Transform competent cells 
11. Aliquot 10 ng of DNA in a volume of 10 to 25 ul into a 15-m1 sterile, round- 
bottom test tube and place on ice. 
Plasmid DNA can be used directly from ligation reactions. When this is done, more 
DNA is usually used. However, if there is more than 1 ug of DNA in the ligation 
reaction, or if the ligation reaction is from low gelling/melting temperature agarose, it 
is wise to dilute the ligation mix 
12. Rapidly thaw competent cells by warming between hands and dispense 100 ul 
immediately into test tubes containing DNA. Gently swirl tubes to mix, then place on 
ice for 10 min. 
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Competent cells should be used immediately after thawing. Remaining cells should be 
discarded rather than refrozen. 
13. Heat shock cells by placing tubes into a 42C water bath for 2 min. 
Alternatively, incubate at 37C for 5 min. 
14. Add 1 ml LB medium to each tube. Place each tube on a roller drum at 250 rpm 
for 1 hr at 37C. 
15. Plate aliquots of transformation culture on LB/ampicillin or other appropriate 
antibiotic-containing plates. 
It is convenient to plate several different dilutions of each transformation culture. The 
remainder of the mixture can be stored at 4C for subsequent platings. 
16. When plates are dry, incubate 12 to 16 hr at 37C. 
Materials 
SOC medium 
0.5% yeast extract 
2% tryptone 
10 mM NaCl 
2.5 mM KC1 
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10 mM MgC12 
10 mM MgSO4 
20 mM glucose 
4.5 AGAROSE GEL ELECTROPHORESIS 
Agarose gel electrophoresis is a simple and highly effective method for separating, 
identifying, and purifying 0.5- to 25-kb DNA fragments. The protocol can be divided 
into three stages: (1) a gel is prepared with an agarose concentration appropriate for 
the size of DNA fragments to be separated; (2) the DNA samples are loaded into the 
sample wells and the gel is run at a voltage and for a time period that will achieve 
optimal separation; and (3) the gel is stained or, if ethidium bromide has been 
incorporated into the gel and electrophoresis buffer, visualized directly upon 
illumination with UV light. 
4.6 RESOLUTION OF DNA FRAGMENTS ON STANDARD AGAROSE 
GELS 
Materials 
Electrophoresis buffer (TAE or TBE ) 
Ethidium bromide solution 
Electrophoresis-grade agarose 
I Ox loading buffer 
DNA molecular weight markers 
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Horizontal gel electrophoresis apparatus 
Gel casting platform 
Gel combs (slot formers) 
DC power supply 
Method 
Preparing the gel 
1. Prepare an adequate volume of electrophoresis buffer (TAE or TBE ) to fill the 
electrophoresis tank and prepare the gel. 
To facilitate visualization of DNA fragments during the run, ethidium bromide 
solution can be added to the electrophoresis buffer to a final concentration of 0.5 
ug/mi. If buffer is prepared for the electrophoresis tank and the gel separately, be sure 
to bring both to an identical concentration of ethidium bromide. 
2. Add the desired amount of electrophoresis-grade agarose to a volume of 
electrophoresis buffer sufficient for constructing the gel. Melt the agarose in a 
microwave oven or autoclave and swirl to ensure even mixing. Gels typically contain 
0.8 to 1.5% agarose 
Melted agarose should be cooled to 55C in a water bath before pouring onto the gel 
platform. This prevents warping of the gel apparatus. Gels are typically poured 
between 0.5 and 1 cm thick. The volume of the sample wells will be determined by 
both the thickness of the gel and the size of the gel comb. 
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3. Seal the gel casting platform if it is open at the ends. Pour in the melted agarose 
and insert the gel comb, making sure that no bubbles are trapped underneath the 
combs and all bubbles on the surface of the agarose are removed before the gel sets. 
Most gel platforms are sealed by taping the open ends with adhesive tape. As an 
added measure to prevent leakage, hot agarose can be applied with a Pasteur pipet to 
the joints and edges of the gel platform and allowed to harden. 
Loading and running the gel 
4. After the gel has hardened, remove the tape from the open ends of the gel platform 
and withdraw the gel comb, taking care not to tear the sample wells. 
Most gel platforms are designed so that 0.5 to I mm of agarose remains between the 
bottom of the comb and the base of the gel platform. This is usually sufficient to 
ensure that the sample wells are completely sealed and to prevent tearing of the 
agarose upon removal of the comb. Low percentage gels and gels made from low 
gelling/melting temperature agarose should be cooled at 4C to gain extra rigidity and 
prevent tearing. 
S. Place the gel casting platform containing the set gel in the electrophoresis tank. 
Add sufficient electrophoresis buffer to cover the gel to a depth of about 1 mm (or 
just until the tops of the wells are submerged). Make sure no air pockets are trapped 
within the wells. 
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6. DNA samples should be prepared in a volume that will not overflow the gel wells 
by addition of the appropriate amount of lOx loading buffer. Samples are typically 
loaded into the wells with a pipettor or micropipet. Care should be taken to prevent 
mixing of the samples between wells. 
Be sure to include appropriate DNA molecular weight markers 
7. Be sure that the leads are attached so that the DNA will migrate into the gel toward 
the anode or positive lead. Set the voltage to the desired level, typically 1 to 10 V/cm 
of gel, to begin electrophoresis. The progress of the separation can be monitored by 
the migration of the dyes in the loading buffer. 
8. Turn off the power supply when the Bromphenol Blue dye from the loading buffer 
has migrated a distance judged sufficient for separation of the DNA fragments. If 
ethidium bromide has been incorporated into the gel, the DNA can be visualized by 
placing on a UV light source and can be photographed directly. 
Gels that have been run in the absence of ethidium bromide can be stained by covering 
the gel in a dilute solution of ethidium bromide (0.5 ug/ml in water) and gently 
agitating for 10 to 30 min. If necessary, gels can be destained by shaking in water for 
an additional 30 min. This serves to remove excess ethidium bromide which causes 
background fluorescence and makes visualization of small quantities of DNA difficult. 
REAGENTS AND SOLUTIONS 
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Agarose gel 
Gels typically contain -1% agarose in lx TAE or TBE . Electrophoresis-grade 
agarose powder is added to 1x gel buffer and melted by boiling for several minutes. 
Be sure all agarose particles are completely melted. To facilitate visualization of DNA 
fragments during the run, ethidium bromide can be added to 0.5 ug/ml in the gel. 
Materials 
Ethidium bromide solution 
1000x stock solution 0.5 ug/ml: 
50 mg ethidium bromide 
100 ml H2O 
Working solution, 0.5 ug/ml: 
Dilute stock 1: 1000 for gels or stain solution 
lOx loading buffer 
20% Ficoll 400 
0.1 M Na2EDTA, pH 8 
1.0% sodium dodecyl sulfate 
0.25% Bromphenol blue 
0.25% Xylene Cyanol (optional; runs -50% as fast as Bromphenol blue and can 
interfere with visualization of bands of moderate molecular weight, but can be helpful 
for monitoring very long runs) 
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4.7 DIGESTING A SINGLE DNA SAMPLE WITH RESTRICTION 
ENDONUCLEASES 
Restriction endonuclease cleavage is accomplished simply by incubating the enzyme(s) 
with the DNA in appropriate reaction conditions. The amounts of enzyme and DNA, 
the buffer and ionic concentrations, and the temperature and duration of the reaction 
will vary depending upon the specific application. 
Materials 
DNA sample in H2O or TE buffer. 
I Ox restriction endonuclease buffers. 
Restriction endonucleases. 
lOx loading buffer. 
0.5 M EDTA, pH 8.0. 
Method 
1. Pipet the following into a clean microcentrifuge tube: 
x ul DNA (0.1 to 4 ug DNA in H2O or TE buffer) 
2 ul lOx restriction buffer. 
18-xulH2O. 
2. Add restriction endonuclease (1 to 5 U/ug DNA) and incubate the reaction mixture 
1 hr at the recommended temperature (in general, 37C). 
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In principle, 1U restriction endonuclease completely digests 1 ug of purified DNA in 
60 min using the recommended assay conditions. However, crude DNA preparations, 
such as those made by rapid procedures, often require more enzyme and/or more time 
for complete digestion. The volume of restriction endonuclease added should be less 
than 1/10 the volume of the final reaction mixture, because glycerol in the enzyme 
storage buffer may interfere with the reaction. 
3. Stop the reaction and prepare it for agarose or acrylamide gel electrophoresis by 
adding 5 ul (20% of reaction vol) 1 Ox loading buffer. 
The reaction can also be stopped by chelating Mg2+ with 0.5 ul of 0.5 M EDTA 
(12.5 mM final concentration). If the digested DNA is to be used in subsequent 
enzymatic reactions (e. g., ligation or "filling-in" reactions), addition of EDTA should 
be avoided. Alternatively, many enzymes can be irreversibly inactivated by incubating 
10 min at 65C. Some enzymes that are partially or completely resistant to heat 
inactivation at 65C may be inactivated by incubating 15 min at 75C. When the 
enzyme(s) is completely resistant to heat inactivation, DNA may be purified from the 
reaction mixture by extraction with phenol and precipitation in ethanol. 
4.8 DNA-DEPENDENT DNA POLYMERASES. 
INTRODUCTION 
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All DNA polymerases add deoxyribonucleotides to the 3'-hydroxyl terminus of a 
primed double-stranded DNA molecule 
Synthesis is exclusively in a 5'->3' direction with respect to the synthesized strand. 
Each nucleotide that is incorporated during polymerization is complementary to the 
one opposite to it in the template (dA pairs with dT, dC with dG). The reaction 
requires the four deoxyribonucleoside triphosphates (dNTPs) and magnesium ions. 
Many DNA polymerases have a 3'->5' exonuclease inherently associated with the 
polymerase activity. The 3'->5' exonuclease activity removes a single nucleotide at a 
time, releasing a nucleoside 5' monophosphate. In the absence of dNTPs, this activity 
will catalyze stepwise degradation from a free 3'-hydroxyl end of both single- and 
double-stranded DNA. In the presence of dNTPs, the exonuclease activity on double- 
stranded DNA is inhibited by the polymerase activity. During DNA synthesis, the 
exonuclease activity performs a proofreading function by removing misincorporated 
nucleotides. 
In addition to the 3'->5' exonuclease activity, some DNA polymerases (e. g., E. coli 
DNA polymerase I) also have an associated 5'->3' exonuclease activity. This activity 
degrades double-stranded DNA from a free 5'-hydroxyl end . 
The 5'->3' exonuclease activity removes from one to several nucleotides at a time, 
releasing predominantly nucleoside 5' phosphates, but also some larger 
oligonucleotides up to 10 nucleotides in length. The 5'->3' exonuclease activity of E. 
coli DNA polymerase I enables it to initiate synthesis from nicks in duplex DNA. The 
5'->3' exonuclease degrades the DNA ahead of the synthesizing polymerase, resulting 
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in translocation of the nick. The 5'->3' exonuclease activity of E. coli DNA 
polymerase I, which is located at the N-terminus of the molecule, can be removed 
either by protease treatment or by deletion of the relevant part of the gene. The 
resulting DNA polymerase, which retains the 3' to 5' exonuclease, is referred to as the 
E. coli DNA polymerase I large fragment, or the Klenow fragment. 
An important property of DNA polymerases is their processivity. Processivity is the 
ability of a polymerase molecule to incorporate nucleotides continuously on a given 
primer without dissociating from the primer template. Most DNA polymerases (e. g., 
E. coli DNA polymerase I, Klenow fragment, T4 DNA polymerase) have low 
processivity; they dissociate from a primer template after incorporating fewer than 10 
nucleotides. In contrast, T7 DNA polymerase is highly processive; it can incorporate 
thousands of nucleotides from a given primer without dissociating from the primer 
template. This is a useful property when long stretches of DNA are being synthesized. 
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4.9 ENZYME KLENOW FRAGMENT OF ESCHERICHIA COLI DNA 
POLYMERASE I 
Introduction 
The Klenow fragment, molecular weight 76,000, consists of the C-terminal, 70% of 
E. coli DNA polymerase I. It retains the DNA polymerase and 3'->5' exonuclease 
activity of E. coli DNA polymerase I, but lacks the 5'->3' exonuclease activity. 
4.10 LABELING CIRCULAR PERMUTE PROBS AT 3' ENDS OF DNA. 
Method 
1. In a 20-ul reaction mixture, add 0.1 to I ug of digested and purified DNA 
(fragments from circular permutations have a length of about 146 bps) with a 
restriction endonuclease that generates 5' overhanging ends 
DNA fragments with blunt ends (e. g. probe D, digested with Eco RV) can be labeled 
inefficiently by replacement of the nucleotide at the 31-hydroxyl terminus. For 
endonucleases that produce 3' overhanging ends, labeling of 3' termini must be carried 
out by replacement synthesis using T4 DNA polymerase. 
2. Add 20 uCi of the desired [a-32P]dNTP (3000 Ci/mmol) and I ul of appropriate 5 
mM 3dNTP mix. If higher specific activities are required, add 80 uCi of the 
radioactive dNTP at 5000 Ci/mmol. 
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Since the Kienow fragment incorporates nucleotides that are complementary to the 
single-stranded, 5' extensions, the choice of 32P-labeled dNTP depends on the 
restriction endonuclease used to cleave the DNA. For example, labeling of BamHI 
ends (GATC, fragment A) can be accomplished with any of the radioactive 
precursors, whereas labeling of EcoRI ends (AATT, fragment G) requires either 
radioactive dATP or dTTP. 
3. Add 1U of the Klenow fragment and incubate 15 min at 30C. 
It is unnecessary to change buffers, or to repurify the DNA prior to adding the 
Klenow fragment. 
4. Stop the reaction with I ul of 0.5 M EDTA or by heating to 75C for 10 min. If 
desired, remove unincorporated dNTP precursors from labeled DNA. 
Critical Parameters of Labeling 3' Ends 
For DNA fragments that are 146 bp in length, the above procedure will generate 
DNA with a specific activity of about 200 cpm/ug. For situations where higher 
specific activities are desired, use radioactive dNTPs of higher specific activity ( 5000 
Ci/mmol). 
DNA can also be labeled selectively at one end by cleaving with two different 
restriction endonucleases and labeling with a 32P-labeled dNTP that is complementary 
to only one of the two 5' extensions. For example, if DNA is cleaved with EcoRI 
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(AATT) and BamHI (GATC), the BamHI ends can be selectively labeled by using 
32P-labeled dGTP. Alternatively, DNA can be cleaved with one enzyme, radiolabeled, 
and then cleaved with the second enzyme. In this case, it is important to inactivate the 
Klenow fragment by heating to 75C for 15 min prior to addition of the second 
restriction enzyme. 
4.11 REPAIRING 3' OR 5' OVERHANGING ENDS TO GENERATE BLUNT 
ENDS. 
For many cloning experiments, it is necessary to convert the ends generated by 
restriction endonucleases into blunt ends. 
Method 
1. In a 20-u1 reaction, digest 0.1 to 4 ug DNA with a restriction endonuclease. 
2. Add 1 ul of 0.5 mM each dNTP. 
3. Add 1 to 5U of the Klenow fragment and incubate at 30C for 15 min. 
Repair of 5' extensions is carried out by polymerase activity, whereas repair of 3' 
extensions is carried out by 3' to 5' exonuclease activity. Due to the relative inactivity 
of exonuclease, this method is not desirable in cases where extensive repair of 
overhanging 3' ends is required. In such situations, T4 DNA polymerase (a much 
more expensive enzyme) or native T7 DNA polymerase are better choices. 
4. Stop the reaction by heating to 75C for 10 min or by adding 1 ul of 0.5 M EDTA. 
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For restriction fragments produced by cleavage with different endonucleases, it is 
possible to repair one end selectively. This is done by cleaving with enzyme 1, 
repairing the ends, inactivating the Klenow fragment by heat (75C for 10 min), and 
cleaving with enzyme 2. 
4.12 ENZYME T4 DNA POLYMERASE 
Introduction 
T4 DNA polymerase, the product of gene 43 of bacteriophage T4, is either prepared 
from cells of E. coli that have been infected with the phage or has been overproduced 
from its cloned gene. T4 DNA polymerase is a single polypeptide of molecular weight 
112,000. In addition to its DNA-dependent DNA polymerase activity, it has a very 
active single-stranded and double-stranded 3'->5' exonuclease. It lacks a 5'->3' 
exonuclease activity. T4 DNA polymerase by itself has low processivity; however, in 
the presence of several T4 accessory proteins, it becomes very processive. This 
polymerase has been produced from a clone that overexpresses its gene . 
Materials 
For 50-u1 reaction: 
50 mM Tris-Cl, pH 8.0 
5 mM MgC12 
5 mM DTT 
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2 ug DNA 
100 uM 4dNTP mix 
50 ug/ml BSA 
10 U T4 DNA polymerase. 
Method 
Incubate 20 min at II C. 
Stop reaction by adding 2 ul of 0.5 M EDTA or by heating to 75C for 10 min. The 
volume of reaction, concentration of 4 dNTPs, and the temperature of the reaction 
will vary, depending upon the individual application. 
Effect of Triphosphate Concentration 
For reaction conditions that do not require radioactive labeling of the DNA, high 
concentrations (100 uM) of dNTPs are used to maximize the ratio of polymerase to 
exonuclease activity. In labeling experiments, the concentration of the labeled dNTP is 
reduced to I to 2 uM; this maximizes the specific activity of the DNA. Levels lower 
than 1 uM labeled dNTP should not be used because once the dNTPs are exhausted 
the exonuclease activity will degrade the DNA. 
Buffer Compatibility 
For most applications, T4 DNA polymerase is used following digestion with 
restriction endonucleases. For many restriction enzymes, cleavage can be carried out 
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in T4 DNA polymerase buffer, and T4 DNA polymerase can be used directly. If 
buffers for the restriction enzyme and T4 DNA polymerase are incompatible, the 
DNA should be digested with the restriction enzyme and then repurified by phenol 
extraction, ethanol precipitation, and resuspension in TE buffer prior to treatment 
with T4 DNA polymerase. 
4.13 ENZYME ALKALINE PHOSPHATASES: BACTERIAL ALKALINE 
PHOSPHATASE AND CALF INTESTINE PHOSPHATASE 
Introduction 
Bacterial alkaline phosphatase (BAP) from E. coli and calf intestine phosphatase 
(CIP) from veal are commonly used in nucleic acid research. Both enzymes catalyze 
the hydrolysis of 5'-phosphate residues from DNA, RNA, and ribo- and 
deoxyribonucleoside triphosphates. The dephosphorylated products possess 5'- 
hydroxyl termini which can subsequently be radioactively labeled using [gamma- 
32P]ATP and T4 polynucleotide kinase ( e. g., probe D, digested with EcoRV, which 
originates blunt ends). 
Both phosphatases require Zn2+ for activity. The primary difference between them is 
the stability of the two enzymes. CIP is readily inactivated by heating to 70C for 10 
min and/or extraction with phenol. On the other hand, BAP is much more resistant to 
these treatments. Thus, for most purposes, CIP is the enzyme of choice. Furthermore, 
CIP has a 10- to 20-fold higher specific activity than BAP. 
We used vectors (pT7-7) dephosphorilated to prevent self ligation. 
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4.14 CIP REACTION. CONDITION FOR DEPHOSPHORYLATION OF DNA. 
Materials 
For 50-u1 reaction: 
20 mM Tris-Cl, pH 8.0 
1 mM MgC12 
1 mM ZnC12 
I to 20 pmol DNA termini 
0.1 U CIP 
Method 
Incubate at 37C for 30 min. Stop reaction by heating to 75C for 10 min or extracting 
with phenol, and then precipitate with ethanol. NOTE: CIP is heat labile; 10 min at 
75C effectively inactivates CIP. 
The volume of reaction and concentration of DNA will vary, depending upon the 
individual application. In general, phosphatase treatment can be done directly 
following cleavage by a restriction endonuclease, thus minimizing the number of 
manipulations. 
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4.15 ENZYME T4 POLYNUCLEOTIDE KINASE 
The forward reaction of T4 polynucleotide kinase catalyzes the transfer of the 
terminal (gamma) phosphate of ATP to the 5'-hydroxyl termini of DNA and RNA. 
This reaction is very efficient and hence is the general method for labeling 5' ends or 
for phosphorylating oligonucleotides. 
The exchange reaction of T4 polynucleotide kinase catalyzes the exchange of 5'- 
terminal phosphates. In this reaction, which requires an excess of ADP, the 5'-terminal 
phosphate is transferred to ADP and subsequently rephosphorylated by the transfer 
from the gamma phosphate of [gamma-32P]ATP. The exchange reaction is less 
efficient than the forward reaction; thus, it is rarely used. 
Finally, polynucleotide kinase is a 3' phosphatase. Some commercial preparations of 
polynucleotide kinase are prepared from the phage T4 strain am N81 pseTi, which 
has a mutated pseT gene. This derivative lacks the 3' phosphatase activity. 
4.16 LABELING 5' ENDS BY THE FORWARD REACTION. 
For 30-u1 reaction: 
Materials 
50 mM Tris-Cl pH 7.5 
10 mM MgC12 
5 mM DTT 
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1 to 50 pmol dephosphorylated DNA, 5' ends (fragment D, digested with EcoRV) 
50 pmol (150 uCi) [gamma-32P]ATP (specific activity >3000 Ci/mmol) 
50ug/mIBSA 
20 U T4 polynucleotide kinase 
Method 
Incubate the above amounts of enzyme, buffer DNA and radiactive ATP at 37C for 
60 min. 
Stop the reaction by adding 1 ul of 0.5 M EDTA or by heating to 75C for 10 min. 
Extract with phenol/chloroform. 
Separate the labeled DNA from the unincorporated labeled nucleotides by filtration on 
Sephadex G-100 or by centrifugation through a spin column containing Sephadex G- 
50. 
The volume of reaction and the concentration of DNA and [y-32P]ATP will vary, 
depending upon the application. 
To phosphorilate synthetic oligonucleotides by the forward reaction, 
Materials 
for 30-u1 reaction: 
50 mM Tris-Cl, pH 7.5 
10 mM MgC12 
5 mM DTT 
1 to 10 ug oligonucleotide linker 
1 MM ATP 
50 ug/mI BSA 
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20 U T4 polynucleotide kinase 
Incubate at 37C for 60 min. Stop reaction by adding 1 ul of 0.5 M EDTA. If desired, 
['y -32P]ATP can be added to trace the reaction. 
4.17 LABELING 5' TERMINI BY THE EXCHANGE REACTION 
For 30-u1 reaction: 
Materials 
50 mM imidazole-Cl, pH 6.6 
10 mM MgC12 
5 mM DTT 
1 to 50 pmol phosphorylated DNA, 5' ends 
5 mM ADP 
60 pmol (180 uCi) [y -32P]ATP (specific activity >3000 Ci/mmol) 
50 ug/ml BSA 
20 U T4 polynucleotide kinase 
Method 
Incubate at 37C for 60 min. Stop reaction by adding 1 ul of 0.5 M EDTA. Extract 
with buffered phenol. Separate the labeled DNA from the unincorporated labeled 
nucleotides by either Sephadex G-100 gel filtration or centrifugation through a spin 
column containing Sephadex G-50. 
The volume of reaction and the concentration of DNA and [y -32P]ATP will vary, 
depending upon the application. 
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4.18 ENZYME T4 DNA LIGASE 
Introduction 
T4 DNA ligase, the product of gene 30 of phage T4, was originally purified from 
phage-infected cells of E. coli. The phage T4 gene 30 has been cloned, and the 
enzyme is now prepared from overproducing strains. Using ATP as a cofactor, T4 
DNA ligase catalyzes the repair of single-stranded nicks in duplex DNA and joins 
duplex DNA restriction fragments having either blunt or cohesive ends. It is the only 
ligase that efficiently joins blunt-end termini under normal reaction conditions. 
Materials 
For 50-ui reaction: 
40 mM Tris-Cl, pH 7.5 
10 mM MgC12 
10 mM DTT 
1 ug DNA 
0.5 mM ATP 
50 uglml BSA 
I "Weiss" U T4 DNA ligase 
Method 
Incubate at 12-30C for 1 to 16 hr. Stop reaction by adding 2 ul of 0.5 M EDTA or by 
heating to 75C for 10 min. The volume of reaction, concentration of DNA, and the 
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temperature and time of the reaction will vary, depending upon the individual 
application. One Weiss unit is equivalent to 60 cohesive-end units. 
Ligation of cohesive ends is usually carried out at 12-15C to maintain a good balance 
between annealing of the ends and activity of the enzyme. Higher temperatures make 
it difficult for the ends to anneal, whereas lower temperatures diminish ligase activity. 
Blunt-end ligations are typically performed at room temperature since annealing is not 
a factor (the enzyme is not particularly stable above 30C). Blunt-end ligations require 
about 10 to 100 times more enzyme than cohesive-end ligations to achieve an equal 
efficiency. T4 DNA ligase is not inhibited by tRNA, but it is strongly inhibited by 
NaCl concentrations >150 mM. Macromolecular exclusion molecules (e. g., PEG 
8000) have been shown to greatly increase the rate of both cohesive-end and blunt- 
end joining by T4 DNA ligase. An inherent consequence of macromolecular crowding 
is that all ligations are intermolecular; thus, this technique is not suitable for the 
ligation and circularization of inserts and vectors that are required for most cloning 
experiments. 
4.19 SUBCLONING OF DNA FRAGMENTS 
In order to construct new DNA molecules, the starting DNAs are treated with 
appropriate restriction endonucleases and other enzymes if necessary (pT7-7 was 
digested with Ndel and EcoRI, p Bend 2 was digested with Xbal and Sall). The 
individual components of the desired DNA molecule are purified by agarose or 
polyacrylamide gel electrophoresis, combined, and treated with DNA ligase. The 
products of the ligation mixture (along with control mixtures) are introduced into 
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competent E. coli cells, and transformants are identified by an appropriate genetic 
selection. DNA is prepared from the colonies or plaques and subjected to restriction 
endonuclease mapping in order to determine if the desired DNA molecule was 
created. All cloning experiments follow the steps outlined below. 
Materials 
Calf intestine phosphatase (CIP) and buffer. 
dNTP mix (0.5 mM each) 
Klenow fragment of E. coli DNA polymerase I or T4 DNA polymerase 
Oligonucleotide linkers. 
10 mM ATP 
0.2 mM dithiothreitol (DTT) 
T4 DNA ligase (measured in cohesive-end units. 
2x T4 DNA ligase buffer 
Methods 
1. In a 20-u1 reaction mixture, cleave the individual DNA components with 
appropriate restriction endonuclease. Vector pT7-7 and fragment of PCR containing 
SRY boxes were digested with endonucleases Mel and Hindff, pBend2 with Xbal 
and Sall. After the reaction is complete, inactivate the enzymes by heating 15 min to 
75C. 
Reaction mixtures can be done in any volume; 20 ul is convenient for gel 
electrophoresis. Many of the subsequent enzymatic manipulations can be carried out 
sequentially without further buffer changes. 
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2. To remove the 5' phosphates of vectors pT7-7 and p Bend 2 (to prevent self 
ligation), add 2 ul of lOx CIP buffer and IU CIP; incubate 30 to 60 min at 37C as 
described before. After the reaction is complete, inactivate CIP by heating 15 min to 
75C. . 
3. If one or both ends generated by a restriction endonuclease must be converted to 
blunt ends add 1 ul of a solution containing all 4 dNTPs (0.5 mM each) and an 
appropriate amount of the Klenow fragment of E. coli DNA polymerase I or T4 DNA 
polymerase; carry out the filling-in or trimming reaction. After the reaction is 
complete, inactivate the enzymes by heating 15 min to 75C. 
4. Isolate the desired DNA segments by gel electrophoresis, or by other methods if 
appropriate. 
Electrophoresis in agarose gels is the most common method. Purification is not 
essential for many cloning experiments, but it is usually very helpful. 
5. Using longwave UV light for visualization of the DNA, cut out the desired band(s) 
and purify the DNA away from the gel material using the procedures described. 
It is critical to use longwave W light sources to prevent damage to the DNA. If low 
gelling/melting temperature agarose is used, ligation reactions can usually be 
performed directly in the gel slice (see alternative protocol). 
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6. Set up the following ligation reaction: 
7 ul component DNAs (0.1 to 5 ug: the molar ratio between vector and insert is 1: 1) 
10 ul 2x ligase buffer 
1 ul 10 mM ATP 
20 to 500 U (cohesive end) T4 DNA ligase 
Incubate Ito 24 hr at 15C. 
Simple ligations with two fragments having 4-bp 3' or 5' overhanging ends require 
much less ligase than more complex ligations or blunt-end ligations. The quality of the 
DNA will also affect the amount of ligase needed. 
For simplicity, appropriate DNAs should be added to each tube (adding water if 
necessary) so that the volume is 9 ul. Immediately prior to use, premix on ice the 
remaining ingredients (2x buffer, ATP, enzyme) in sufficient amounts for all the 
reactions. To start the ligation reactions, add 11-u1 aliquots of the premix to each tube 
containing DNA. 
8. Introduce 1 to 10 ul of the ligated products into competent E. coli cells and select 
for transformants by virtue of the genetic marker present on the vector. 
9 From individual E. coli transformants, purify plasmid or phage DNAs by miniprep 
procedures and determine their structures by restriction mapping and sequencing. 
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4.20 ALTERNATIVE PROTOCOL: LIGATION OF DNA FRAGMENTS IN 
GEL SLICES 
This alternate protocol saves considerable time in comparison to the basic protocol 
because it eliminates purification of the DNA fragments away from the gel matrix. It 
is suitable for most simple cloning experiments and is particularly valuable for carrying 
out a set of hybrid constructions involving a variety of different DNA fragments. 
However, as the cloning efficiency may be reduced, this method should be employed 
only when it is desired to make one (or relatively few) specific molecules. 
Additional Materials 
Low gelling/melting temperature agarose (SeaPlaque, FMC Marine Colloids) 
TAE buffer 
Method 
1. Treat the starting DNAs with appropriate restriction endonucleases and other 
enzymes. 
2. Subject the treated DNAs to electrophoresis in low gelling/melting temperature 
agarose using TAE buffer. 
It is critical that the agarose be of high ' quality. SeaPlaque is a good choice. The 
agarose concentration should be kept as low as possible (0.7% is suitable for most 
applications). 
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3. Cut out the desired band of linear vectors and fragments in the smallest possible 
volume (20 to 50 ul) using a clean razor blade, and place the gel slice in a 
microcentrifuge tube. 
4. Melt the gel slices containing DNA at 70C for at least 10 min. 
This temperature is hot enough to melt the agarose without denaturing the DNA. 
5. In separate tubes for each ligation reaction, combine the gel slices containing 
appropriate DNAs (and water if necessary) for a total volume of 9 ul. Place the tubes 
at 37C for a few minutes. 
The gel slices should remain molten at 37C. 
6. To each tube containing DNA, add 11 ul of an ice-cold mixture containing 2x 
buffer, ATP, and T4 DNA ligase. Mix immediately by flicking the tube and place on 
ice. Then incubate the reaction mixtures 1 to 48 hr at 15C. 
DNA fragments can still be ligated even though the reaction mixture has resolidified 
into a gel. 
7. After the ligation reaction is complete, remelt the gel slices 5 to 10 min at 73C and 
add 5 ul of the ligated products to 200 ul of competent E. coli cells. 
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The remelted gel must be diluted at least 30-fold so that it does not resolidify when 
the cells are placed on ice. 
Materials 
2x T4 DNA ligase buffer 
100 mM Tris-Cl, pH 7.5 
20 mM MgC12 
20 mM DTT 
4.21 CONSTRUCTION OF RECOMBINANT DNA FRAGMENT OF SRY 
BOXES BY POLYMERASE CHAIN REACTION. 
INTRODUCTION 
Any two segments of DNA can be ligated together into a new recombinant molecule 
using the polymerase chain reaction (PCR). The DNA can be joined in any 
configuration, with any desired junction-point reading frame or restriction site, by 
incorporating extra nonhomologous nucleotides within the PCR primers. Cloning by 
PCR is often more rapid and versatile than cloning with standard techniques that rely 
on the availability of naturally occurring restriction sites and require microgram 
quantities of DNA. It is not necessary to know the nucleotide sequence of the DNA 
being subcloned by this technique, other than the two short flanking regions (--20 bp) 
that serve as anchors for the two oligonucleotide primers used in the amplification 
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process. Moreover, PCR can be performed on low-abundance or even degraded DNA 
(or RNA) sources. 
Important variables that can influence the outcome of PCR include the MgC12 
concentration and the cycling temperatures. Additives that promote polymerase 
stability and processivity or increase hybridization stringency, and strategies that 
reduce nonspecific primer-template interactions, especially prior to the critical first 
cycle, can greatly improve sensitivity, specificity, and yield. 
4.22 SUBCLONING DNA FRAGMENTS 
In this protocol, synthetic oligonucleotides incorporating new unique restriction sites 
are used to amplify a region of DNA to be subcloned into a vector containing 
compatible restriction sites. The amplified DNA fragment is purified, subjected to 
enzymatic digestion at the new restriction sites, and then ligated into the vector. 




30 mM MgC12 
lOx MgC12-free PCR amplification buffer 
25 mM 4dNTP mix 
50 uM oligonucleotide primer 1: 50 pmol/ul in sterile H2O (store at -20C) 
50 uM oligonucleotide primer 2: 50 pmol/ul in sterile H2O (store at -20C) 
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Template DNA: 1 ug mammalian genomic DNA 
5 U/ul Taq DNA polymerase 
DMSO, cell culture grade 
Glycerol 
Taq DNA polymerase 
Mineral oil 
Automated thermal cycler 
MgC12-free PCR amplification buffer, lOx 
500 mM KCl 
100 mM Tris-Cl, pH 9.0 (at 25C) 
0.1% Triton X-100 
Store indefinitely at -20C 
This buffer can be obtained from Promega; it is supplied with Taq DNA polymerase. 
4dNTP mix 
For 2 mM 4dNTP mix: Prepare 2 mM each dNTP in TE buffer, pH 7.5. Store up to 1 
year at -20C in 1-ml aliquots. 
For 25 mM 4dNTP mix: Combine equal volumes of 100 mM dNTPs (Promega). 
Store indefinitely at -20C in 1-ml aliquots. 
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TE-buffered phenol and chloroform 
100% ethanol 
TE buffer, pH 8.0 
Klenow fragment of E. coli DNA polymerase I 
Vector DNA 
Calf intestinal phosphatase 
Additional reagents and equipment for enzymatic amplification of DNA by PCR, 
agarose and polyacrylamide gel electrophoresis, DNA extraction and precipitation, 
purification of DNA by glass beads, electroelution from agarose gels, or from low- 
gelling/melting temperature agarose gels, restriction endonuclease digestion, ligation 
of DNA fragments, transformation of E. coli, plasmid DNA minipreps, and DNA 
sequence analysis. 
Amplify the target DNA 
Method 
1. Prepare the template DNA. If using an impure DNA preparation, heat sample 10 
min at 1000 to inactivate nucleases. 
Genomic DNA from patients and primates provided by Goodfellow's group were 
used as the source of target DNA. 
2. Prepare oligonucleotide primers. 
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Oligonucleotides SRYboxdir (CCACATATGCAGGATAGAGTGAAGCGA)). and 
SRYboxrev (CGAAGCTTAACGACGAGGTCGATACTT) were synthesised. 
Because the purity of the oligonucleotides does not seem to affect the PCR reaction, 
primer purification may not be necessary. Sites for restriction endonucleases Ndel and 
Hindlll are underlined. 
Oligonucleotides SRYboxdir and SRYboxrev were synthesised by the phosphotriester 
method. 
3. Set up a standard amplification reaction and overlay with mineral oil. 1. Carry out 
PCR in an automated thermal cycler. PCR mixtures (50 µl) contained 50 pmol each of 
oligonucleotides SRYboxdir and SRYboxrev, 0.2 mM dNTPs, 400 ng purified total 
genomic DNA, 1 unit Taq DNA polymerase and 5 pl Taq polymerise 10 X buffer 
(Perkin-Elmer Cetus). Twenty five cycles of denaturation (30 s at 94C), annealing (60 
s at 50C) and polymerisation (60 s at 72C) were performed. Extention of an 
additional 10 min at 72C in the last cycle made products as complete as possible. 
Include negative controls of no template DNA and each oligonucleotide alone, as well 
as several different oligonucleotide: template ratios. 
Recover the amplified fragment as described . 
4. Analyze an aliquot (e. g., 4 to 8 ul) of each reaction mix by agarose gel 
electrophoresis to verify that the amplification has yielded the expected product. 
III 
5. Recover amplified DNA from PCR reaction mix. Remove mineral oil overlay from 
each sample, then extract sample once with buffered chloroform to remove residual 
mineral oil. Extract once with buffered phenol and then precipitate DNA with 100% 
ethanol. 
6. Microcentrifuge DNA 10 min at high speed, 4C. Dissolve pellet in 20 ul TE buffer. 
Purify desired PCR product from unincorporated nucleotides, oligonucleotide 
primers, unwanted PCR products, and template DNA using glass beads, 
electroelution, or phenol extraction of low gelling/melting temperature agarose. 
Unused oligonucleotide primers can inhibit the ability of the restriction enzymes to 
digest the amplified PCR product. 
Prepare amplified fragment and vector for ligation. 
7. Since primers contain unique restriction sites, digest half of the amplified DNA in 
20 ul with the appropriate restriction endonucleases (Hind III and Nde I for SRY 
boxes). Use an excess of enzyme, and digest for several hours. 
Reserve the undigested half for future use, if necessary. 
8. Prepare the recipient vector pT7-7 for cloning by digesting 0.2 to 2 ug in 20 ul with 
NdeI-HindLU restriction enzymes; althought not necessary, since the vector could not 
be completely digested, treat vector DNA with calf intestinal phosphatase to prevent 
recircularization during ligation. 
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9. Separate the linearized vector from uncut vector by agarose or low-gelling/melting 
temperature gel electrophoresis. Recover linearized vector from the gel by adsorption 
to glass beads, electroelution, or phenol extraction of low-gelling/melting temperature 
agarose. 
10. Ligate the PCR fragments into the digested vector. 
11. Transform an aliquot of each ligation into E. coli. Prepare plasmid miniprep DNA 
from a subset of transformants. 
Analyze recombinant plasmids 
12. Digest the plasmid DNA of the selected transformants with Mel and Hindill 
restriction endonucleases. Analyze the digestions by agarose gel electrophoresis to 
confirm fragment incorporation. 
13. Sequence the amplified fragment portion of the plasmid DNA to check for 
mutations. 
This analysis is critical because the Taq DNA polymerase can introduce mutations 
into the amplified fragment. 
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4.23 DNA SEQUENCING STRATEGIES 
INTRODUCTION 
Any double-stranded template used in dideoxy sequencing should be denatured before 
being annealed to the primer. In general practice, alkali denaturation of plasmid DNA 
works better for sequencing than heat denaturation 
4.24 ALKALI DENATURATION OF DOUBLE-STRANDED PLASMID DNA 
FOR DIDEOXY SEQUENCING 
Theoretically, it should be possible to denature double-stranded templates either by 
treating with alkali or by boiling and achieve equal results in sequencing. In practice, 
however, alkali denaturation of closed-circular double-stranded templates and I 
templates usually gives superior results for dideoxy sequencing. 
In the procedure described below, a recombinant plasmid is denatured using NaOH. 
After adjusting the pH to 7.0, the DNA is precipitated with ethanol, washed, and 
dried. The dried pellet is suitable to be added to annealing reactions prior to DNA 
sequencing reactions 
Materials 
Recombinant plasmid DNA 2M NaOH/2 mM EDTA 
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3M sodium acetate, pH 6.0 
95% and 70% ethanol 
0.5-m1 microcentrifuge tubes 
Method 
1. Add -0.5 pmol of recombinant plasmid DNA pT7-SRYbox-wt, M641, I94M, 
G95R, K1061 and F109S to a 0.5-m1 microcentrifuge tube. If the volume is >20 ul, 
ethanol precipitate the DNA and redissolve in 20 ul water. If the volume is <20 ul, 
add water to bring the volume to 20 ul. 
0.5 pmol of a 2.5-kbp plasmid is -0.8 ug. 
2. Add 2 ul of 2M NaOH/2 mM EDTA and gently mix by drawing up and down with 
a pipet. Incubate 5 min at 25-37C. 
3. Place sample on ice, add 7 ul water, and mix thoroughly by drawing solution up 
and down with the pipettor. 
4. Add 7 ul of 3M sodium acetate, pH 6.0 (to neutralize DNA solution). Mix 
thoroughly by drawing solution up and down with the pipettor. Check the pH of the 
solution by spotting 1 ul on pH paper. Add 3M sodium acetate, pH 6.0 until the pH is 
=7.0. 
5. Add 75 ul of 95% ethanol and place 10 min on dry ice. 
6. Microcentrifuge 10 min, 4C, and carefully remove and discard the supernatant. 
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Use caution when removing the ethanol because the DNA pellet may also be 
removed. 
7. Add 400 ul 70% ethanol. Microcentrifuge 10 min at 4C, then carefully remove and 
discard the ethanol layer. 
8. Dry pellet 10 min in a Speedvac evaporator. Store the pellet at 20C (up to several 
weeks) until used as template for dideoxy sequencing reactions 
4.25 LABELING/TERMINATION SEQUENCING REACTIONS USING 
SEQUENASE 
The labeling/termination sequencing protocol involves two steps. In the labeling step, 
primed DNA synthesis is initiated in the presence of limiting concentrations of all four 
dNTPs, including [a-35S]dATP, and continues until one of the dNTP pools is 
depleted. At this point, the uniformly labeled DNA chains are distributed randomly in 
length from a few nucleotides to hundreds of nucleotides. In the second step, 
synthesis resumes in the presence of additional dNTPs and one ddNTP. Elongation of 
the DNA chains in this step is rapid and processive until termination occurs at specific 
bases after incorporation of the corresponding dideoxynucleotide. In this protocol, the 
average length of the radioactively labeled oligonucleotide products is modified by 
altering the concentration of dNTPs in the first step; however, it can also be regulated 
by altering the dNTP: ddNTP ratio in the termination reaction 
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This basic protocol uses Sequenase. The labeling/termination procedure can also be 
used with other polymerases; however, because each polymerase has different buffer 
and Mg++ concentration optima, and each discriminates to a different extent against 
ddNTPs, the concentrations of these components must be modified in each case. 
Materials 
0.5 pmol single-stranded or denatured double-stranded DNA template 
0.5 to 1 pmol/ul oligonucleotide primer in water (store at -20C) 
lOx Sequenase buffer 




10 mCi/ml [a-35S]dATP (500 to 1200 Ci/mmol) 
Stop/loading dye 
0.5-m1 microcentrifuge tubes 
Heat-resistant microtiter plates. 
Anneal primer and template 
Method 
lb. Resuspend a dried pellet containing 0.5 pmol denatured double-stranded DNA in 
the following mixture: 
1 pmol primer T7 for pT7 vector, M13 for pbend2 (pharmacia). 
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1 ul lOx Sequenase buffer 
H20 to 10 u1. 
Mix gently by pipetting up and down (avoid creation of bubbles). Incubate 30 min at 
37C, then keep at this annealing temperature until ready to proceed to step 2. 
0.8 ug of 2500-bp double-stranded DNA molecule corresponds to 0.5 pmol of 
template molecules. Double-stranded DNA templates require twice as much primer as 
single-stranded DNA templates. For more stringent annealing conditions, incubate at 
42-50C instead of 37C. 
Set up termination reactions 
2. While the primer is being annealed to the template, label four microcentrifuge tubes 
A, C, G, and T for each template to be sequenced. 
For simultaneous sequencing of a large number of templates, the reactions can be 
carried out in heat-resistant, round-bottom, 96-well microtiter plates with heat- 
resistant lids 
3. Add 2.5 ul each of A, C, G, and T Sequenase termination mixes to the bottom of 
the A, C, G, and T tubes, respectively. 
Keep tubes closed because the small volumes evaporate rapidly when open to the air. 
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Carry out labeling reaction 
4. Immediately before use, dilute the Sequenase/pyrophosphatase mix in Sequenase 
diluent to I to 2U Sequenase/ul and keep on ice. 
5. Add the following to the annealed primer and template: 
2 ul labeling mix 
0.5 to 1.5 ul 10 mCi/ml [a-35S]dATP 
2 ul diluted Sequenase/pyrophosphatase mix. 
The total volume is 14.5 to 16 ul. Incubate 5 min at 25C (room temperature). 
Choose the labeling mix appropriate for the lengths of sequencing products that are 
desired. Reaction times can be extended to 20 min without detriment, although the 
reaction is complete within 5 min, by which time the nucleotide pools are exhausted. 
This step can be performed at 37C; however, 25C limits the processivity of the 
Sequenase, an advantage during the labeling step, and maximizes its half-life during 
the sequencing reaction. 
At least 3 pmol of [a35S]dATP are required for reactions containing the short 
labeling mixes whereas 15 pmol must be added to reactions containing the long 
labeling mixes. Amounts greater than these are not incorporated during the labeling 
step, because the other three dNTPs become limiting. The concentration of [a- 
35S]dATP at 10 mCi/mI with a specific activity of 1000 Ci/mmol is 10 uM. Thus for 
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such a preparation, 0.3 and 1.5 ul are sufficient for the labeling step with the short and 
long labeling mixes, respectively. 
Carry out termination reaction 
6. Add 3.5 ul of the labeling reaction mixture to the tube containing Sequenase 
termination mix A (from step 3). Mix the solution by gently pipetting up and down. 
Repeat this addition to the C, G, and T tubes, changing pipet tips each time. Incubate 
5 to 10 min at 37C. 
Reactions are complete within 2 to 3 min but incubations can be extended to 30 min 
without problems except when using dITP under some conditions 
7. Add 4 ul stop/loading dye. 
35S sequencing reactions may be stored for up to one week at -20C before 
electrophoresis. 
8. Heat samples 2 min in a 95C water bath, then place on ice. Load 2 to 3 ul of each 
sample on a sequencing gel. Electrophorese the gel and read the sequence . 
Excessive boiling of the completed reactions in formamide/dye solution may cause 
DNA chain breakage and smeared bands on the sequencing gel. If repeated loadings 
are planned, remove a3 ul aliquot of each reaction to heat before each loading. 
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4.26 COLORIMETRIC METHODS FOR QUANTIFYING PROTEINS. 
4.27 BRADFORD METHOD 
The Bradford method depends on quantitating the binding of a dye, Coomassie 
brilliant blue, to an unknown protein and comparing this binding to that of different 
amounts of a standard protein, usually bovine serum albumin. It is designed to 
quantify 1 to 10 ug protein. 
Materials 
0.5 mg/ml bovine serum albumin (BSA) 
0.15 M NaCl 
Coomassie brilliant blue solution 
Method 
1. Into 8 microcentrifuge tubes aliquot duplicate amounts of 0.5 mg/ml BSA (5,10, 
15, and 20 ul) and with 0.15 M NaCl bring the volume in each to 100 ul. Into 2 
microcentrifuge tubes, aliquot 100 ul of 0.15 M NaCl; these are blank tubes. 
2. Add 1 ml Coomassie brilliant blue solution and vortex. Allow to stand 2 min at 
room temperature. 
3. Determine the As95 using a 1-cm pathlength microcuvette (1 ml) and make a 
standard curve by plotting absorbance at 595 nm versus protein concentration. 
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Determine the absorbance for the unknown and use the standard curve to determine 
the concentration of protein in the unknown. 
If the unknown protein concentration is too high, dilute the protein, assay a smaller 
aliquot of the unknown, or generate another standard curve in a higher concentration 
range (e. g., 10 to 100 ug). 
REAGENTS AND SOLUTIONS 
0.5 mg/ml bovine serum albumin (BSA) 
The concentration of BSA is determined using the A280 = 6.6 for a 10 mg/ml solution 
of BSA measured in a 1-cm pathlength cuvette (e. g., a 0.5 mg/ml solution will have 
anA28o=0.33). 
Coomassie brilliant blue solution 
In a 1-liter volumetric flask, dissolve 100 mg Coomassie brilliant blue G-250 in 50 ml 
of 95% ethanol. Add 100 ml of 85% phosphoric acid Bring to volume with water. 
Filter through Whatman No. 1 filter paper. Store at 4C. 
Commercial kits are available from Pierce (#23200) and Bio-Rad (#500-0006). 
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4.28 GEL ELECTROPHORESIS 
4.29 DENATURING (SDS) DISCONTINUOUS GEL ELECTROPHORESIS: 
LAEMMLI GEL METHOD 
One-dimensional gel electrophoresis under denaturing conditions (i. e., in the presence 
of 0.1% SDS) separates proteins based on molecular size as they move through a 
polyacrylamide gel matrix toward the anode. The polyacrylamide gel is cast as a 
separating gel (sometimes called resolving or running gel) topped by a stacking gel 
and secured in an electrophoresis apparatus. After sample proteins are solubilized by 
boiling in the presence of SDS, an aliquot of the protein solution is applied to a gel 
lane, and the individual proteins are separated electrophoretically. 2-Mercaptoethanol 
(2-ME) or dithiothreitol (DTT) is added during solubilization to reduce disulfide 
bonds. 
This protocol is designed for a vertical slab gel with a maximum size of 0.75 mm x 14 
cm x 14 cm. For thicker gels, or minigels the volumes of stacking and separating gels 
and the operating current must be adjusted. 
Materials 
Separating and stacking gel solutions 
H20-saturated isobutyl alcohol 
lx Tris-CUSDS, pH 8.8 (dilute 4x Tris-CUSDS, pH 8.8) 
Protein sample to be analyzed 
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2x and lx SDS sample buffer. 
Protein molecular-weight-standards mixture. 
6x SDS sample buffer. 
lx SDS electrophoresis buffer. 
Electrophoresis apparatus: Protean II 16-cm cell (Bio-Rad) or SE 600/400 16-cm unit 
(Hoefer Pharmacia Biotech) with clamps, glass plates, casting stand, and buffer 
chambers 
0.75-mm spacers 
0.45-um filters (used in stock solution preparation) 
25-ml Erlenmeyer side-arm flask 
Vacuum pump with cold trap 
0.75-mm Teflon comb with 1,3,5,10,15, or 20 teeth 
25- or 100-u1 syringe with flat-tipped needle 
Constant-current power supply 
Pour the separating gel 
Method 
1. Assemble the glass-plate sandwich of the electrophoresis apparatus according to 
manufacturer's instructions using two clean glass plates and two 0.75-mm spacers. 
If needed, clean the glass plates in liquid Alconox or RBS-35 (Pierce). These 
aqueous-based solutions are compatible with silver and Coomassie blue staining 
procedures. 
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2. Lock the sandwich to the casting stand. 
3. Prepare the separating gel solution degassing using a rubber-stoppered 25-m1 
Erlenmeyer side-arm flask connected with vacuum tubing to a vacuum pump with a 
cold trap. After adding the specified amount of 10% ammonium persulfate and 
TEMED to the degassed solution, stir gently to mix. 
The stacking gel is the same regardless of the separating gel used. 
The desired percentage of acrylamide in the separating gel depends on the molecular 
size of the protein being separated. Generally, use 5% gels for SDS-denatured 
proteins of 60 to 200 kDa, 10% gels for SDS-denatured proteins of 16 to 70 kDa, and 
15% gels for SDS-denatured proteins of 12 to 45 kDa 
4. Using a Pasteur pipet, apply the separating gel solution to the sandwich along an 
edge of one of the spacers until the height of the solution between the glass plates 
is-11 cm. 
Use the solution immediately; otherwise it will polymerize in the flask. 
Sample volumes <10 ul do not require a stacking gel. In this case, cast the resolving 
gel as you normally would, but extend the resolving gel into the comb to form the 
well. The proteins are then separated under the same conditions as used when a 
stacking gel is present. Although this protocol works well with single-concentration 
gels, a gradient gel is recommended for maximum resolution 
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5. Using another Pasteur pipet, slowly cover the top of the gel with a layer (-1 cm 
thick) of H20-saturated isobutyl alcohol, by gently layering the isobutyl alcohol 
against the edge of one and then the other of the spacers. 
Be careful not to disturb the gel surface. The overlay provides a barrier to oxygen, 
which inhibits polymerization, and allows a flat interface to form during gel formation. 
The H20-saturated isobutyl alcohol is prepared by shaking isobutyl alcohol and H2O 
in a separatory funnel. The aqueous (lower) phase is removed. This procedure is 
repeated several times. The final upper phase is H20-saturated isobutyl alcohol. 
6. Allow the gel to polymerize 30 to 60 min at room temperature. 
A sharp optical discontinuity at the overlay/gel interface will be visible on 
polymerization. Failure to form a firm gel usually indicates a problem with the 
ammonium persulfate, TEMED (N, N, N', N'-tetramethylethylenediamine), or both. 
Ammonium persulfate solution should be made fresh before use. Ammonium 
persulfate should "crackle" when added to the water. If not, fresh ammonium 
persulfate should be purchased. Purchase TEMED in small bottles so, if necessary, a 
new previously unopened source can be tried. 
Pour the stacking gel 
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7. Pour off the layer of H20-saturated isobutyl alcohol and rinse with lx Tris- 
HCVSDS, pH 8.8. 
Residual isobutyl alcohol can reduce resolution of the protein bands; therefore, it must 
be completely removed. The isobutyl alcohol overlay should not be left on the gel 
longer than 2 hr. 
8. Prepare the stacking gel solution. 
Use the solution immediately to keep it from polymerizing in the flask. 
9. Using a Pasteur pipet, slowly allow the stacking gel solution to trickle into the 
center of the sandwich along an edge of one of the spacers until the height of the 
solution in the sandwich is -1 cm from the top of the plates. 
Be careful not to introduce air bubbles into the stacking gel. 
10. Insert a 0.75-mm Teflon comb into the layer of stacking gel solution. If necessary, 
add additional stacking gel to fill the spaces in the comb completely. 
Again, be careful not to trap air bubbles in the tooth edges of the comb; they will 
cause small circular depressions in the well after polymerization that will lead to 
distortion in the protein bands during separation. 
11. Allow the stacking gel solution to polymerize 30 to 45 min at room temperature. 
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A sharp optical discontinuity will be visible around wells on polymerization. 
Prepare the sample and load the gel 
12. Dilute a portion of the protein sample to be analyzed 1: 1 (v/v) with 2x SDS 
sample buffer and heat 3 to 5 min at 1000 in a sealed screw-cap microcentrifuge tube. 
If the sample is a precipitated protein pellet, dissolve the protein in 50 to 100 ul of 1x 
SDS sample buffer and boil 3 to 5 min at 100C. Dissolve protein-molecular-weight 
standards mixture in lx SDS sample buffer according to supplier's instructions as a 
control. 
For dilute protein solutions, consider adding 5: 1 protein solution/6x SDS sample 
buffer to increase the amount of protein loaded. Proteins can also be concentrated by 
precipitation in acetone, ethanol, or trichloroacetic acid (TCA), but losses will occur. 
For a 0.8-cm-wide well, 25 to 50 ug total protein in <20 ul is recommended for a 
complex mixture when staining with Coomassie blue, and 1 to 10 ug total protein is 
needed for samples containing one or a few proteins. If silver staining is used, 10- to 
100-fold less protein can be applied (0.01 to 5 ug in <20 ul depending on sample 
complexity). 
To achieve the highest resolution possible, the following precautions are 
recommended. Prior to adding the sample buffer, keep samples at OC. Add the SDS 
sample buffer (room temperature) directly to the OC sample (still on ice) in a screw- 
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top microcentrifuge tube. Cap the tube to prevent evaporation, vortex, and transfer 
directly to a 100C water bath for 3 to 5 min. Let immunoprecipitates dissolve for 1 hr 
at 56C in lx SDS sample buffer prior to boiling. DO NOT leave the sample in SDS 
sample buffer at room temperature without first heating to a 1000 to inactivate 
proteases. Endogenous proteases are very active in SDS sample buffer and will cause 
severe degradation of the sample proteins after even a few minutes at room 
temperature. To test for possible proteases, mix the sample with SDS sample buffer 
without heating and leave at room temperature for 1 to 3 hr. A loss of high- 
molecular-weight bands and a general smearing of the banding pattern indicate a 
protease problem. Once heated, the samples can sit at room temperature for the time 
it takes to load samples. 
13. Carefully remove the Teflon comb without tearing the edges of the polyacrylamide 
wells. After the comb is removed, rinse wells with lx SDS electrophoresis buffer. 
The rinse removes unpolymerized monomer; otherwise, the monomer will continue to 
polymerize after the comb is removed, creating uneven wells that will interfere with 
sample loading and subsequent separation. 
14. Using a Pasteur pipet, fill the wells with lx SDS electrophoresis buffer. 
If well walls are not upright, they can be manipulated with a flat-tipped needle 
attached to a syringe. 
15. Attach gel sandwich to upper buffer chamber using manufacturer's instructions. 
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16. Fill lower buffer chamber with the recommended amount of lx SDS 
electrophoresis buffer. 
17. Place sandwich attached to upper buffer chamber into lower buffer chamber. 
18. Partially fill the upper buffer chamber with lx SDS electrophoresis buffer so that 
the sample wells of the stacking gel are filled with buffer. 
Monitor the upper buffer chamber for leaks and if necessary, reassemble the unit. A 
slow leak in the upper buffer chamber may cause arcing around the upper electrode 
and damage the upper buffer chamber. 
19. Using a 25- or 100-ul syringe with a flat-tipped needle, load the protein sample(s) 
into one or more wells by carefully applying the sample as a thin layer at the bottom 
of the wells. Load control wells with molecular weight standards. Add an equal 
volume of lx SDS sample buffer to any empty wells to prevent spreading of adjoining 
lanes. 
Preparing the samples at approximately the same concentration and loading an equal 
volume to each well will ensure that all lanes are the same width and that the proteins 
run evenly. If unequal volumes of sample buffer are added to wells, the lane with the 
larger volume will spread during electrophoresis and constrict the adjacent lanes, 
causing distortions. 
130 
The samples will layer on the bottom of the wells because the glycerol added to the 
sample buffer gives the solution a greater density than the electrophoresis buffer. The 
bromphenol blue in the sample buffer makes sample application easy to follow 
visually. 
20. Fill the remainder of the upper buffer chamber with additional lx SDS 
electrophoresis buffer so that the upper platinum electrode is completely covered. Do 
this slowly so that samples are not swept into adjacent wells. 
Run the gel 
21. Connect the power supply to the cell and run at 10 mA of constant current for a 
slab gel 0.75 mm thick, until the bromphenol blue tracking dye enters the separating 
gel. Then increase the current to 15 mA. 
For a standard 16-cm gel sandwich, 4 mA per 0.75-mm-thick gel will run -15 hr (i. e., 
overnight); 15 mA per 0.75-mm gel will take 4 to 5 hr. To run two gels or a 1.5-mm- 
thick gel, simply double the current. When running a 1.5-mm gel at 30 mA, the 
temperature must be controlled (10-20C) with a circulating constant-temperature 
water bath to prevent "smiling" (curvature in the migratory band). Temperatures <5C 
should not be used because SDS in the running buffer will precipitate. If the level of 
buffer in the upper chamber decreases, a leak has occurred. 
22. After the bromphenol blue tracking dye has reached the bottom of the separating 
gel, disconnect the power supply. 
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Disassemble the gel 
23. Discard electrode buffer and remove the upper buffer chamber with the attached 
gel sandwich. 
24. Orient the gel so that the order of the sample wells is known, remove the 
sandwich from the upper buffer chamber, and lay the sandwich on a sheet of 
absorbent paper or paper towels. 
25. Carefully slide one of the spacers halfway from the edge of the sandwich along its 
entire length. Use the exposed spacer as a lever to pry open the glass plate, exposing 
the gel. 
26. Carefully remove the gel from the lower plate. Cut a small triangle off one corner 
of the gel so the lane orientation is not lost during staining and drying. Proceed with 
protein detection. 
The gel can be stained with Coomassie blue or silver or proteins can be electroeluted. 
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4.30 ALTERNATIVE PROTOCOL 1: ELECTROPHORESIS IN TRIS- 
TRICINE BUFFER SYSTEMS 
Separation of peptides and proteins under 10 to 15 kDa is not convenient in the 
traditional Laemmli discontinuous gel system. This is due to the comigration of SDS 
and smaller proteins, obscuring the resolution. Two approaches to obtain the 
separation of small proteins and peptides in the range of 5 to 20 kDa are presented: 
this Tris-tricine method that follows and a system using increased buffer 
concentrations. The Tris-tricine system uses a modified buffer to separate the SDS 
and peptides, thus improving resolution. Several precast gels are available for use with 
the tricine formulations. 
Additional Materials 
Separating and stacking gel solutions 
2x tricine sample buffer 
Peptide molecular-weight-standards mixture 
Cathode buffer 
Anode buffer 
Coomassie blue G-250 staining solution 
10% (v/v) acetic acid 
Method 
1. Prepare and pour the separating and stacking gels. 
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2. Prepare the sample but make the following changes for tricine gels. Substitute 2x 
tricine sample buffer for the 2x SDS sample buffer. Dilute an aliquot of the protein or 
peptide sample to be analyzed 1: 1 (v/v) with 2x tricine sample buffer. Treat the 
sample at 40C for 30 to 60 min prior to loading. 
If proteolytic activity is a problem, heating samples to 100C for 3 to 5 min before 
loading the wells may be required. Use the peptide molecular-weight-standards 
mixture for peptide separations. 
3. Load the gel and set up the electrophoresis apparatus with the following 
alterations. Remove comb and, using the tricine-containing cathode buffer, or water, 
rinse once and fill wells. Fill the lower buffer chamber with anode buffer, assemble the 
unit, and attach the upper buffer chamber. Fill the upper buffer chamber with cathode 
buffer and load the samples. 
4. Connect the power supply to the cell and run 1 hr at 30 V (constant voltage) 
followed by 4 to 5 hr at 150 V (constant voltage). Use heat exchanger to keep the 
electrophoresis chamber at room temperature. 
5. After the tracking dye has reached the bottom of the separating gel, disconnect the 
power supply. 
Coomassie blue G-250 is used as a tracking dye instead of bromphenol blue because it 
moves ahead of the smallest peptides. 
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6. Disassemble the gel. Stain proteins in the gel for 1 to 2 hr in Coomassie blue G-250 
staining solution. Follow by destaining with 10% acetic acid, changing the solution 
every 30 min until background is clear (3 to 5 changes). For higher sensitivity, use 
silver staining as a recommended alternative. 
Prolonged staining and destaining will result in the loss of resolution of the smaller 
proteins (<10 kDa). Proteins diffuse within the gel and out of the gel, resulting in a 
loss of staining intensity and resolution. 
Materials 
Anode buffer 
121.1 g Tris base 
500 ml H2O 
Adjust to pH 8.9 with concentrated HCl 
Dilute to 5 liters with H2O 
Store at 4C up to I month 
Final concentration is 0.2 M Tris-Cl, pH 8.9. 
Cathode buffer 
12.11 g Tris base 
17.92 g tricine 
1g SDS 
Dilute to 1 liter with H2O 
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Do not adjust pH 
Store at 4C up to 1 month 
Final concentrations are 0.1 M Tris, 0.1 M tricine, and 0.1% (w/v) SDS. 
Coomassie blue G-250 staining solution 
200 ml acetic acid 
1800 ml H2O 
0.5 g Coomassie blue G-250 
Mix 1 hr and filter (Whatman no. 1 paper) 
Store at room temperature indefinitely 
The final solution is 0.025% (w/v) Coomassie blue G-250 in 10% (v/v) acetic acid. 
SDS electrophoresis buffer, 5x 
15.1 g Tris base 
72.0 g glycine 
5.0 g SDS 
H2O to 1000 ml 
Dilute to lx or 2x for working solution, as appropriate 
Do not adjust the pH of the stock solution, as the solution is pH 8.3 when diluted. 
Store at 4C until use (up to 1 month). 
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Tricine sample buffer, 2x 
2 ml 4x Tris-CUSDS, pH 6.8 (Table 10.2.1) 
2.4 ml (3.0 g) glycerol 
0.8 g SDS 
0.31 g DTT 
2 mg Coomassie blue G-250 
Add H2O to 10 ml and mix 
Final concentrations are 0.1 M Tris, 24% (w/v) glycerol, 8% (w/v) SDS, 0.2 M DTT, 
and 0.02% (w/v) Coomassie blue G-250. 
4.31 ALTERNATIVE PROTOCOL: RAPID COOMASSIE BLUE STAINING 
Protein bands stained using this protocol can be detected within 5 to 10 min after 
adding rapid Coomassie staining solution. Because the Coomassie blue concentration 
is lower than that used in the basic protocol, the gel background never stains very 
darkly and the bands can be seen even while the gel remains in the staining solution. 
Another difference from the basic protocol is that isopropanol is substituted for 
methanol in the fixing and destaining solutions. This method is slightly less sensitive 
than the basic protocol. 
Additional Materials 
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Isopropanol fixing solution 
Rapid Coomassie staining solution 
10% acetic acid 
Method 
1. Place the polyacrylamide gel in a plastic or glass container. Cover the gel with 
isopropanol fixing solution and shake gently at room temperature. For a 0.7-mm-thick 
gel, shake 10 to 15 min; for a 1.5-mm thick gel, shake 30 to 60 min. 
2. Pour out fixing solution. Cover the gel with rapid Coomassie blue staining solution 
and shake gently until desired intensity is reached, 2 hrs to overnight at room 
temperature. 
Bands will become visible even in the staining solution within 5 to 30 min, depending 
on gel thickness. The gel background will never stain very darkly. 
3. Pour out staining solution. Cover the gel with 10% acetic acid to destain, shaking 
gently 2 hr at room temperature until a clear background is obtained. 
4. If necessary, pour out 10% acetic acid and add more. Continue destaining until 
clear background is obtained. Store gel in 7% acetic acid or water, or in plastic wrap 
at 4C. 
It is usually unnecessary to add additional destaining solution. 
5. If desired, photograph or dry the gel as in step 7 of the basic protocol. 
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See steps 6 and 7 above concerning photographing or drying the gel. 
Coomassie blue staining solution 
50% methanol (v/v) 
0.05% (w/v) Coomassie brilliant blue R-250 (Bio-Rad or Pierce) 
10% (v/v) acetic acid 
40% H2O 
Dissolve the Coomassie brilliant blue R in methanol before adding acetic acid and 
water. Solution can be stored for 6 months. If precipitate is observed following 
prolonged storage, filter to obtain a homogeneous solution. 
Destaining solution 
5% methanol 
7% acetic acid 
88% H2O 
Can be stored -1 month at room temperature 
4.32 SILVER STAINING 
Detection of protein bands in a gel by silver staining depends on binding of silver to 
various chemical groups (e. g., sulfhydryl and carboxyl moieties) in proteins. The 
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detection limit is 2 to 5 ng/protein band. In this procedure, proteins separated in a 
polyacrylamide gel are successively fixed in methanol/acetic acid and glutaraldehyde. 
After exposure to silver nitrate, the gel is treated with developer to control the level of 
staining. When the desired staining intensity is reached, the gel is fixed, photographed, 
and dried. 
Materials 
Fixing and destaining solutions 
10% (v/v) glutaraldehyde (freshly prepared from 50% stock; Kodak #1200534) 
Silver nitrate solution 
Developing solution 
Kodak Rapid Fix Solution A (#8323917) 
Method 
1. Place the polyacrylamide gel in a plastic container and add 5 gel volumes of fixing 
solution. Agitate slowly 30 min on an orbital shaker. 
2. Pour out fixing solution. Fix the gel with 5 gel volumes of destaining solution for 
60 min, agitating slowly. 
No destaining is taking place in this step; fixation continues using the same solution as 
was used for destaining in the Coomassie blue staining protocol. 
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3. Pour out destaining solution. Add 5 gel volumes of 10% glutaraldehyde and agitate 
slowly 30 min in a fume hood. 
4. Pour out the glutaraldehyde. Wash the gel 4 times with water, 30 min for each 
wash and preferably overnight for the last wash. Agitate slowly with each wash. 
Washing is done by adding the water, pouring it off, and adding more water. 
5. Pour out the water. Stain the gel with -5 gel volumes of silver nitrate solution (to 
cover the gel) for 15 min with vigorous shaking. 
6. Transfer the gel to another plastic box and wash 5 times with deionized water, 
exactly I min for each wash. Agitate slowly with each wash. 
7. Dilute 25 ml developing solution with 500 ml water. Transfer gel to another plastic 
box, add enough diluted developer to cover the gel during agitation, and shake 
vigorously until the bands appear as intense as desired. If the developer turns brown, 
change to fresh developer. 
Development should be stopped immediately when gel background starts to appear. 
8. Transfer to Kodak Rapid Fix Solution A for 5 min. 
If necessary, swab gel surface with soaked cotton to remove residual silver deposits. 
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9. Pour off Rapid Fix Solution and wash the gel exhaustively in water (4 to 5 times). 
10. Photograph the gel. 
It is useful to use a blue-green filter such as a Wratten #58 filter with Kodak T-Max 
100. Gels should be photographed as soon as possible because there may be slight 
changes in color intensity and increases in nonspecific background. The silver-stained 
proteins remain clearly visible for at least 18 hr. 
11. Dry the gel to maintain a permanent record as in step 7 of the first basic protocol 
or store in sealable plastic bag (will last 6 to 12 months). 
4.33 PURIFICATION OF SRY BOXES. 
Day 1 
- Inocolare BL21(DE3) containing pT7 hSRY box in 10 ml of LB + 100ug/ml 
ampicillin + 0.4% glucose. Grow o. n. at 37 degrees. 
Day 2 
- Inoculate 1.5 ml of o. n. colture in one 1 liter flask containing 150 nil of LB + 100 
ug/ml ampicillin. Grow at 37 degrees with strong agitation. 
- Prepare mono S FPLC column (Pharmacia) : wash 2X with program 2/3 and buffers 
A and B. Pressure limit 2.0 Mpa. 
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- When A600=0.6 -0.9 add 1 mM IPTG. Grow at 370 C for 90-100 min (see results 
formore details). 
- Centrifuge cells in GSA rotor 6K rpm for 10 min. at 4° C. Resuspend pellet in 7.5 ml 
buffer L2 and transfer in 50 ml Nalgene tubes. 
- Sonicate the suspension until it clarifies partially. Keep the tube in ice and apply a 
maximum of 8 cycles of 20 seconds (power 100 W); lower amounts of cells require 
fewer cycles. 
- Add 1.5 ml of NaCl 5M and mix thouroughly. 
- Add 7.5 ml of a 50% v/v suspension of DEAE-sephadex in buffer L2 (ice 
temperature). Mix well and keep on ice 5 min. 
- Spin at lOK rpm 10 min. in SS-34 rotor at 4° C. Discard pellet and transfer the 
supernatant in a new Nalgene tube. 
-Add to the supernatant solid ammonium sulphate to final 70% solubility. Let stand 
the tube on ice 20 min. Centrifuge at 10 Krpm 10 min in SS-34 rotor at 4° C. 
- Discard the pellet; tranfer the supernatant in to a 50m1 Falcon tube. 
- Load the supernatant in a superloop of 50 ml. Run column with program 2/2. Select 
the fraction size of 1 ml. 
- At the end of the column run take tubes and transfer to fridge. 
Materials 
buffer L2 
50 mM Tris-HC1 pH 8.0 




20 mM HEPES pH 7.9 
0.5 mM DTT 
0.2 mM EDTA 
buffer B 
20 mM HEPES pH 7.9 
0.5 mM DTT 
0.2 mM EDTA 
2M NaCl 
program 2/3 
0.0 conc %B 
0.0 ml/min 
0.0 valve pos 
0.0 valve pos. 
0.0 nil/mark 
0.0 cm/ml 
0.0 port set 
10 conc %B 












0.0 ml/min 0.25 
0.0 valve pos 2.1 
0.0 valve pos. 1.1 
0.0 ml/mark 1.0 
0.0 cm/ml 0.50 
2.0'valve pos 1.2 
2.0 ml min. 0.2 
2+x valve pos 1.1 
4+x conc%B 100 
4+x port set 6.1 
14+x conc %B 100 
17+x conc %B 100 
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4.34 MOBILITY SHIFT DNA-BINDING ASSAY USING GEL 
ELECTROPHORESIS. 
INTRODUCTION 
The DNA-binding assay using mobility shift polyacrylamide gel electrophoresis 
(PAGE) is a simple, rapid, and extremely sensitive method for the detection of 
sequence-specific DNA-binding proteins in crude extracts. This assay also permits the 
quantitative determination of the affinity, abundance, association rate constants, 
dissociation rate constants, and binding specificity of DNA-binding proteins. Proteins 
that bind specifically to an end-labeled DNA fragment retard the mobility of the 
fragment during electrophoresis, resulting in discrete bands corresponding to the 
individual protein-DNA complexes. 
The protocol can be divided into four stages: (1) an end-labeled DNA probe 
containing a particular protein binding site is prepared; (2) a low-percentage, low- 
ionic-strength polyacrylamide gel is prepared; (3) a protein mixture is bound to the 
DNA probe; and (4) the binding reactions are electrophoresed through the gel, which 
is then dried and autoradiographed. 
MOBILITY SHIFT ASSAY USING LOW-IONIC-STRENGTH PAGE 
Materials 
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DNA with desired binding site (cruciforms DNAs, cD3e, mutl 1 or mut 0 probes). 
TE buffer 
4x binding buffer 
TBE running buffer 
30% ammonium persulfate 
TEMED (N, N, N', N'-tetramethylethylenediamine) 
DNA-binding protein 
Whatman 3MM or equivalent filter paper 
Mehod 
Prepare the DNA probe. Digest, purify and label as described before. 
Prepare enough 0.5X TBE electrophoresis buffer to fill the tank. 
Assemble washed 20-cm-long glass plates and 0.8-mm spacers for casting the gel. 
Use siliconized glass plates to aid removal of the gel after electrophoresis. Wash away 
all traces of detergent since this will disrupt protein-DNA interactions. 
. Add 100 ul of 30% ammonium persulfate and 34 ul TEMED to 40 ml 
low-ionic- 
strength gel mix. Swirl gently to mix. 
A large volume of premixed low-ionic-strength gel mix can be prepared and stored for 
several months at 4C. Allow the gel mix to reach room temperature before adding 
ammonium persulfate and TEMED. It is not necessary to degas the gel mix. 
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. Pour the gel mix between the plates and insert a comb. 
For optimal results, use a 
comb with teeth that are 4 mm wide. 
The polyacrylamide gel contains an 30: 1 ratio of acrylamide to bisacrylamide. 
. 
Allow the gel to completely polymerize for 20 min. Remove the comb and bottom 
spacer and attach the plates to the electrophoresis tank after filling the lower reservoir 
with low-ionic-strength electrophoresis buffer. Fill the upper reservoir of the tank 
with low-ionic-strength electrophoresis buffer. With a bent-needle syringe, remove air 
bubbles trapped beneath the gel and flush out the wells 
. 
Pre-run the gel at 100 V for at least 90 min. 
At 100 V the gel should initially draw a current of -22 mA, and should decrease to 
18 mA after 90 min. 
Prepare the binding buffer 4x: 
20% Ficoll, 400 mM NaCl, 40mM Hepes pH 7.9, bromphenol blue, xylene cyanol. 
In a microtiter combine the following 
10,000 cpm DNA probe 
-4/15 ng of protein from a pure fraction. 
2.5 ul of buffer 4x 
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The final reaction volume is 10 ul. 
Binding reactions must contain -5% Ficoll to minimize mixing of the sample with the 
gel electrophoresis buffer and to ensure that the samples sink to the bottom of the 
wells. While some mixing occurs during loading, this is usually not a problem since 
the electrophoresis buffer is of lower ionic strength than the reaction buffer. This 
increases the stability of most nucleic acid-protein interactions and results in even 
longer-lived complexes. 
. Incubate the binding reaction mix 5 min in ice. 
Run the gel 
. Load a small volume of IOx loading buffer into one of the wells. Allow the dyes to 
run into the gel and flush the wells before loading the samples. 
The dyes can be used to monitor the progress of electrophoresis. 
. Load each binding reaction into the appropriate well with a 10-u1 glass capillary 
pipet and a Clay-Adams screw-top loader or with a pipettor. 
. Electrophorese at -30 to 35 mA until the bromphenol blue approaches the 
bottom of 
the gel (-2.5 to 3 hr). 
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If electrophoresis is performed at room temperature, the glass plates should be 
allowed to become only slightly warm. Decrease the voltage if the plates become any 
hotter. For probes <70 bp, do not run the bromphenol blue to the bottom of the gel. 
To run the gel faster, put the apparatus in a cold room. Higher voltages may then be 
used without heating the glass plates. In addition, colder temperatures cause a 
contraction of the gel, increasing its sieving properties. As a result, protein-DNA 
complexes may appear as sharper bands. 
. Remove the glass plates from the gel box and carefully remove the side spacers. 
. Using a spatula, slowly pry the glass plates apart, allowing air to enter between the 
gel and the glass plate. The gel should remain attached to only one of the plates. 
Prying the plates apart too quickly may tear the gel or cause it to stick to both plates. 
If this occurs or if the gel has become distorted, squirt a stream of water underneath 
it. This will reduce the stickiness of the gel. Be careful not to let the gel slide off the 
plate. 
. Lay the glass plate (with the gel attached) on the bench with the gel facing up. Place 
3 sheets of Whatman filter paper cut to size on top of the gel. 
Support both sides with your hands and carefully flip the sandwich over so that the 
Whatman paper is on the bottom and the glass plate is on the top. 
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. 
Carefully lift up one end of the glass plate. Peel the Whatman paper with the gel 
attached to it from the plate. 
. 
Cover the gel with plastic wrap and dry under vacuum. 
. Autoradiograph the 
dried filter. Visualize the protein-DNA complex after overnight 
exposure without an intensifying screen or after 5-hr exposure with an intensifying 
screen. 
Low-ionic-strength electrophoresis buffer 
0.5 X T. B. E. 
Low-ionic-strength electrophoresis gel 
8% AcrylamideBisacrylamide (30/1) in 0.5 X TBE. 
Filter through 0.4-um filter 
Store at 4C for several months 
4.35 MAKING THE LABELED CROSS 
Four-way junction c is composed of four strands of 30,35,40 and 46 nucleotides. As 
controls for structure-specific binding, two linear duplex DNAs were used, called a 
and b. Details on the construction of these molecules are given in Bianchi et al. 
(1989). 





4) TCTACCAGATTACCCCCGTGTGAGAGCGT. Control duplex az was 
constructed by annealing oligo 1 with its complement oligo 5 
(CAGCTGGGCGGAGGCCCGTGTGAGAGCGCT); the sequences contained in the 
resulting duplex were shown to be. poor binding sites for SRY ( Harley et al., 1992). 
Control duplex bz was constructed by annealing oligo 2 with its complement; the 
resulting duplex is identical to the allmut probe, which was shown previously to be a 
poor binding sites for SRY (Harley et al 
Mix 
20 pmoles of oligo 1 
2 ul of kinase bf 10 X 
12.5 ul of 32P-ATP(5000 uCi/mMmol) 
1.5 ul of T4 polynucleotide Kinase 
water to 20 ul. 
incubate 1 hr at 37° C. 
Add 
30 pmoles of oligo arm 2,3,4. 
water to 30 ul. 
Put the mix in a dry block at 100° C. To allow annealing, switch the mix off the dry 
block, cover it with a lid of polystyrene foam and let it cool until 30° C. Remove and 
throw away condensed vapour from the inner cap. 
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Make a 6.5 % polyacrylamide gel in 0.5 X TBE, 1 mm thick. Prerun at RT, 250 V2 
hours. 
Apply cruciform mix to 2 wells of prerun gel. Run at RT, 250 V for 1.5-2 hours. 
Cruciform structure will be at the level of xylene cyanol or slightly higher. 
Wrap gel in Saran wrap. Autoradiograph it for 1 min. with Fuji film. Mark the film 
with a felt tip pen; markings should extend outside the film into the Saran wrap 
around the gel. 
Cut out the band corresponding to cruciform structure associated to high level of 
radioactivity and put gel slice in Eppendorf. Autoradiograph again as a check. 
Pierce a hole with a needle in the bottom of the eppendorf tube containing the gel 
slice. Put into aa second eppendorf tube and spin a few seconds in centrifuge at 4° C. 
Add to the ground PA gel in the lower tube 600 ul of TE. On a rotary wheel shake the 
tube at4° C for 4 hours. After recover supernatant and pool. Filter the supernatant 
through glass wool in a pierced eppendorf. Filter at 4° C. Assuming the recovery is 
50%, the final cruciform concentration will be 10 nM or 10 fmoles/ul. 
4.36 CIRCULAR PERMUTATION ASSAY. 
Plasmids pBend2 containing DNA sequences CD3e, MUT11 and MUTO were 
prepared by insertion of annealed synthetic oligonucleotides 
(CTAGAGAGCGCTTTGTTCTCAG and TCGACTGAGAACAAAGCGCTCT for 
pBend2CD3e, CTAGAGAGCGCATTGTTATCAG and 
TCGACTGATAACAATGCGCTCT for pBend2MUT 11, 
CTAGAGAGCGCTGTGTTCTCAG and TCGACTGAGAACACAGCGCTCT for 
pB2MUTO) between the Xbal and Sall restriction sites in plasmid pBend2. 
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Preparation of probes, electrophoresis and data analysis were carried out as previously 
reported 
4.37 CALCULATION OF DNA BEND PARAMETERS 
For circular permutation analysis, the mobilities of protein-DNA complexes were 
normalized to the mobility of free DNA (Rbound/Rfree, vertical axis of the graph in 
the figures of results). The distances between the 5' end of the probe and the apparent 
center of flexure were normalized to the total length of the probe (flexure 
displacement, horizontal axis of the graph in the figures of results). The points in the 
graph were interpolated with a second-order equation (a parabola) by means of least 
squares algorithm (application Cricket Graph on a Macintosh computer). 
To analyze the electrophoretic mobilities of the protein-DNA complexes, we adopted 
the Lumpkin-Zimm reptation model, in which the DNA chains migrate in wormlike 
fashion among the gel fibers. The DNA chains are confined to a tube, composed of a 
sequence of segments which connect the consecutive points of contact between the 
DNA and the gel fibers. The mobility of the chain, R, is proportional to the center-of- 
mass velocity, vcm, of the chain in the direction of the electric field, such that: 
R= <vcm>/E _ <hx2/L2> Q/z (equation 1, Levene and Zimm, 1989) 
where the field of strength E is along the x axis, Q is the total charge of the DNA, z is 
the friction constant for motion along the tube, hx is the component in the x direction 
of the tube's end-to-end vector, L is the contour length of the tube, and the angle 
brackets denote an average over an ensemble of conformations. In this model, 
<hx2/L2> can be smaller than unity for two reasons: the introduction of a fixed, 
oriented bend in the DNA molecule, or the presence of an ensemble of non-fixed, 
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non-oriented bends, such as those allowed by a loose hinge. Levene and Zimm (1989) 
have computed with Monte Carlo simulations R and <hx2/L2> for straight and bent 
chains, and have compared them to the experimental electrophoretic mobilities of bent 
DNA molecules. They found that the results are closely approximated by the model if 
one introduces an additional, independently adjustable elastic force constant, Beff, 
which accounts for the relative deformability of gel and DNA. In our analysis, we 
have drastically simplified the mathematical complexity of the real situation and of the 
Levene-Zimm model by adopting the following assumptions: (1) for circularly 
permuted DNA chains of fixed length, Q and z are constant; (2) the flexure introduced 
in the DNA chain by the binding of the protein is an angle, q, with a well-identified 
vertex and a fixed amplitude (as opposed to a continuous bend and a dynamically 
averaged ensemble <q> of amplitudes) and in addition (3) due to the limited length of 
our probes and the ionic strength of the gel system, DNA chains are essentially rigid, 
so that <hx2/L2> can be approximated by hx2/L2; (4) Beff does not vary substantially 
with the displacement of the angle along the circularly permuted DNA molecules. 
Condition 2 is probably the most critical, since situations have been found in which 
the protein-induced flexure resembles more closely a loose hinge than a rigid angle 
(Gartenberg and Crothers, 1988; Kerrpola and Curran, 1991a). Conditions 2 and 4 
can be partially checked by running the complexes in gels of different polyacrylamide 
concentration: the calculated angle amplitudes should not vary significantly. Under the 
conditions specified, equation 1 reduces to: Rbound/Rfree= kbound (hxbound2/L2)/ 
kfree (hxfree2/L2)= K hxbound2/L2 (equation 2) 
where k (and hence K) are constants, and hxfree =L for a straight rod. How does 
hxbound depend on D, the distance of the vertex of the angle q from the 5' end of the 
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DNA molecule ? In a triangle, the length of the three sides a, b and c and the angle g 
subtended by a and b are related by the formula 
c2 = a2 +b2 - 2abcosg (equation 3). 
In our model: 
hxbound2 = D2 + (L-D)2 - 2D(L-D)cosq (equation 4). 
Substituting equation 4 in equation 2 yields 
Rbound/Rfree =K [D2 + (L-D)2 - 2D(L-D)cosq] / L2 = 
= 2K(1+cosq)(D/L)2 - 2K(1+cosq)(D/L) +K (equation 5). 
Thus in our model Rbound/Rfree is a quadratic function of D/L, and the experimental 
values for Rbound/Rfree can be interpolated by a parabola, whose minimum identifies 
the locus of flexure. In addition, the amplitude of q can be readily derived from the 
parameters for the second-order and first-order terms of the equation, both equal to 
2K(1+cosq); K is the zero-order parameter of the same equation. In fact, the 
comparison of the two estimates of the angle q derived from the first- and second- 
order parameters is a good test of the model. 
A similar geometrical treatment of the problem was used by Thompson and Landy 
(1988). They derived the formula pMJpE = cosa/2, which relates the angle of 
deviation from linearity of the DNA, a, to the relative mobilities of complexes with a 
flexure exactly in the middle, µM, or at the end of the molecule, RE. Empirically, the 
formula pM/µE = cosa/2 was found to give a good fit to observed values for a angles 
between 0 and 140 degrees (q angles between 180 and 40). We find that our solution 
gives results numerically similar to Thompson and Landy's and is more accurate and 
robust, since it considers many data points rather than two (pM and µE). 
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4.38 DETERMINATION OF COMPLEX DISSOCIATION CONSTANTS. 
Wild type and mutant SRY boxes were titrated into binding mixtures containing a 
fixed amount (0.25 nM) of labelled cruciform z or of labelled fragment D from 
pBend2CD3e, pBend2CD3eMUTO or pBend2CD3eMUTI 1. Samples were 
electrophoresed at 4C in 10% polyacrylamide gels as described. The radioactivity 
present in the bands was measured by exposing the wet gel to Phosphorlmager 
screens (Molecular Dynamics). Under conditions of protein excess, the dissociation 
constant is equivalent to the concentration of polypeptide where half of the input 
DNA is taken up in the complex (see Results). 
4.39 DETERMINATION OF PROTEIN-DNA SEQUENCE SPECIFICITY BY 
PCR-ASSISTED BINDING-SITE SELECTION. 
Binding-site selection is used to determine the target specificity of a sequence-specific 
DNA-binding protein. The technique has a number of applications, ranging from 
identifying DNA target sequences for proteins with unknown DNA-binding 
specificities to providing additional information on the protein-DNA interactions of 
previously characterized DNA binding domains. 
As indicated in the protocol, a pool of random-sequence oligonucleotides is used as 
the source of potential binding sites . 
The oligonucleotide pool is made double 
stranded, labelled with 32P and incubated in a binding reaction containing the DNA- 
binding protein of interest. Protein-DNA complexes are isolated by electrophoresis in 
a vertical 7% polyacrylamide gel in 0.5X TBE and elecrophoresed at 11 V cm-1 at 
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room temperature. The gel is autoradiographed with Kodak XAR-5 film at 4C for a 
few hours. Bound oligonucleotides are recovered, amplified by the polymerase chain 
reaction (PCR), and used as input DNA for a further round of binding, recovery, and 
amplification. After four rounds of selection, progress of the procedure is monitored 
again by mobility shift analysis of the selected oligonucleotide pools. After five 
rounds, individual binding site isolated from the appropriate complex on a mobility 
shift gel are cloned into plasmids and examined by sequencing. 
Materials 
Random-sequence oligonucleotide R60-mer template, 
5'CTGGTCGGGTGAATTCGTGTCGTGG(A/G/C/T) l OCCGACCCAGCGAATTC 
AGAGCATG; 
upper primer F, CTGGTCGGGTGAATTCGTGTCGTGG; 
lower primer R, ACATGCTCTGAATTCGCTGGGTCGG. 
1 Ox Taq DNA polymerase buffer 
0.5 mM 3dNTP mix (minus dCTP) 
40 uM and 0.5 mM dCTP 
10 mCi/ml [a-32P]dCTP (800 Ci/mmol) 
5 U/ul Taq DNA polymerase 
Elution buffer (see recipe) 
Glycogen carrier (e. g., Boehringer Mannheim) 
TE buffer, pH 7.5 to 8.0 
Binding buffer (see recipe), with and without 50 ug/ml BSA 
Carrier DNA: e. g., 100 ng/ul 
Purified DNA-binding proteins 
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Scintillation vials and counter 
17 x 100-mm polystyrene centrifuge tube with snap-cap 
Tumbler or rotating wheel 
Whatman 3MM paper 
Additional reagents and equipment : 
phenol/chloroform extraction and ethanol precipitation , and mobility shift 
DNA- 
binding assay 
Prepare labeled double-stranded random-sequence oligonucleotide 
Method 
1. Use Purified oligonucleotides R60, primer F, and primer R. Dilute R60 to 50 ng/ul 
and primers F and R to 80 ng/ul in water. 
2. Set up the following reaction in a 0.5-m1 microcentrifuge tube (20 ul total): 
2 ul 50 ng/ul oligonucleotide R76 
2 ul l Ox Taq DNA polymerase buffer 
2 ul 0.5 mM 3dNTP mix (minus dCTP) 
2 u140 um dCTP 
2 u180 ng/ul primer F 
2 ul 10 Ci/ml (3000 Ci/mmol) [a-32P)dCTP 
7 ul H2O 
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1 ul 5 U/ul Taq DNA polymerase. 
3. Carry out one PCR cycle using the following cycling parameters: 
1 min 94C (denaturation) 
3 min 55C (annealing) 
9 min 72C (extension) 
Chase extension by adding 2 ul of 0.5 mM dCTP, then heating 9 min at 72C. 
This reaction will generate double-stranded R60 oligonucleotide (dsR60) labeled to a 
specific activity of 3200 Ci/mmol, which is appropriate for use in a gel mobility shift 
assay . 
Probes with higher specific activity can be generated by increasing the ratio of labeled 
to unlabeled dCTP in the reaction. R60 may also be rendered double-stranded by 
annealing primer F and extending with Klenow fragment of E. coli DNA polymerase I 
4. Purify dsR60 on an 8% nondenaturing polyacrylamide gel visualizing it by 
autoradiography 
A clearly visible dsR60 band can be obtained after a 60- to 90-sec exposure. 
5. Excise gel slice containing labeled dsR60 using a clean scalpel and place in a 1.5-ml 
microcentrifuge tube containing 250 ul elution buffer. Incubate overnight at 37C. 
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6. Remove elution buffer to a fresh 1.5-m1 microcentrifuge tube, add 1 ug of glycogen 
carrier, and ethanol precipitate. 
7. Resuspend pellet in 10 ul TE buffer and measure 1 ul into a scintillation vial. 
Measure Cerenkov counts in a scintillation counter to determine cpm. 
Because the molecular weight and specific activity of the probe oligonucleotide are 
known, the amount of dsR60 can be quantitated by assuming that 106 cpm is 
approximately equivalent to I uCi. The double-stranding reaction in step 2 and the 
PCR amplification reaction in step 22 contain [a-32P]dCTP and unlabeled dCTP at 
concentrations such that four labeled C nucleotides are incorporated into every dsR60 
oligonucleotide. The specific activity of dsR76 is therefore four times the specific 
activity of the [a-32P]dCTP itself (4 x 3000 Ci/mmol = 12000 Ci/mmol). 
8. Prepare a 0.2 ng/ul dilution of dsR60 in TE buffer for use in binding reaction 
9. Incubate probes with proteins as describe for band shift assay. 
10. Apply the binding mix to a 7% acrylamide gel, and allow it to run for two hours at 
30 mAs. 
11. Purify dsR60-protein complex visualizing it by autoradiography 
A clearly visible dsR60 band can be obtained after two hours of exposure. 
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12. Excise gel slice containing labeled dsR60 using a clean scalpel and place in a 1.5- 
ml microcentrifuge tube containing 250 ul elution buffer. Incubate overnight at 37C. 
13. Remove elution buffer to a fresh 1.5-mi microcentrifuge tube, perform a phenol 
extraction followed by a chloroform extraction, add 1 ug of glycogen carrier, and 
ethanol precipitate. 
Determination of the proportion of the input probe associated to the protein 
compared to the unbound DNA allows quantitation of selected DNA. In addition, the 
proportion of input DNA recovered after each round of selection often gives a good 
indication of the progress of the site selection. 
Amplify selected DNA 
14. Prepare the following reaction mixture (20 ul total): 
2 ul lOx Taq DNA polymerase buffer 
3.2 ul 0.5 mM 3dNTP mix (minus C) 
2 ul 40 uM dCTP 
2 ul 80 ng/ul primer F 
2 u180 ng/ul primer R 
1u 10 mCi/ml (800 Ci/mmol) [a-32P]dCTP 
7.3 ul H2O 
0.5 ul 5 U/ul Taq DNA polymerase. 
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Add this mixture to 1 pg of selected DNA in a 0.5-ml microcentrifuge tube. 
15. Carry out 30 of the following radioactive PCR amplification cycles: 
1 min 94C (denaturation) 
1 min 55C (annealing) 
30 sec. 72C (extension) 
This step is optimized for amplification of oligonucleotide R60 with primers F and R. 
It is important to carefully calibrate the amplification reaction with respect to the 
amount of input DNA and number of PCR cycles performed particularly when using 
different random oligonucleotide/primer combinations. 
16. Dilute PCR reaction to 150 ul with TE buffer and phenol extract 
17. Add 1 ug of glycogen carrier and 1/4 vol of 5M ammonium acetate (to 1 M). 
Ethanol precipitate 
18. Purify PCR product by electrophoresis on a nondenaturing polyacrylamide gel as 
described in steps 4 to 6. 
Because maximum recovery is not absolutely essential, the elution step can be cut to 2 
brat 45C. 
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19. Following ethanol precipitation, resuspend pellet in 10 ul TE buffer and measure 1 
ul for Cerenkov counts. Quantitate selected, amplified dsR76, then resuspend at 0.1 
ng/ul. 
This procedure typically yields 10 to 20 ng labeled amplified selected dsR60 
oligonucleotide. 
20. Use the selected and amplified oligonucleotide pool in another round of binding- 
site selection. After five selection cycles, monitor the success of the binding-site 
selection procedure with a band shift assay. 
If successful, four rounds of selection should yield oligonucleotide pools that are 
capable of forming visible and abundant protein-DNA complexes on a mobility shift 
gel 
Controls are critical, and should include binding reactions in which a oligonucleotide 
containing the ipotetical binding site is incubated with the protein under investigation 
(positive control). 
Binding reactions with probes derived from consecutive rounds of selection should be 
loaded adjacent to the positive control on the mobility shift gel. This allows the 
gradual appearance of specific complexes to be easily visualized. 
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4.40 ISOLATION AND ANALYSIS OF BOUND OLIGONUCLEOTIDES 
FROM MOBILITY SHIFT GELS 
Once the success of the site selection procedure has been confirmed by mobility shift 
analysis, bound oligonucleotides are isolated from appropriate mobility shift 
complexes by direct amplification from gel slices. Bound oligonucleotides are then 
digested with restriction enzyme EcoRI and subcloned for sequence analysis of 
individual selected sites. 
Molecules are ligated into the vector and transformed into E. coli. Sequence analysis 
of individual selected sites was performed. 
Elution buffer 
0.5 M ammonium acetate 
1 mM EDTA 
0.1% SDS 
Store several months at room temperature 
Recovery buffer 
50 mM Tris-Cl, pH 8 
100 mM sodium acetate 
5 mM EDTA 
0.5% SDS 
Store several months at room temperature 
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